WO2022200867A1 - Edge-sealed porous substrate diagnostic devices and methods of making same - Google Patents
Edge-sealed porous substrate diagnostic devices and methods of making same Download PDFInfo
- Publication number
- WO2022200867A1 WO2022200867A1 PCT/IB2022/050692 IB2022050692W WO2022200867A1 WO 2022200867 A1 WO2022200867 A1 WO 2022200867A1 IB 2022050692 W IB2022050692 W IB 2022050692W WO 2022200867 A1 WO2022200867 A1 WO 2022200867A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polymeric
- porous substrate
- substrate
- region
- metallic
- Prior art date
Links
- 239000000758 substrate Substances 0.000 title claims abstract description 389
- 238000000034 method Methods 0.000 title claims abstract description 65
- 229920001577 copolymer Polymers 0.000 claims abstract description 266
- 230000002209 hydrophobic effect Effects 0.000 claims description 103
- 239000003153 chemical reaction reagent Substances 0.000 claims description 80
- 239000012491 analyte Substances 0.000 claims description 45
- 239000002657 fibrous material Substances 0.000 claims description 34
- 239000000463 material Substances 0.000 claims description 34
- 239000000203 mixture Substances 0.000 claims description 33
- 239000000835 fiber Substances 0.000 claims description 28
- -1 polyethylene Polymers 0.000 claims description 22
- 238000007789 sealing Methods 0.000 claims description 22
- 239000011148 porous material Substances 0.000 claims description 16
- 238000007639 printing Methods 0.000 claims description 15
- 239000000178 monomer Substances 0.000 claims description 12
- 238000004026 adhesive bonding Methods 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 238000004080 punching Methods 0.000 claims description 9
- 239000004698 Polyethylene Substances 0.000 claims description 7
- 239000011248 coating agent Substances 0.000 claims description 7
- 238000000576 coating method Methods 0.000 claims description 7
- 229920000573 polyethylene Polymers 0.000 claims description 7
- 230000005855 radiation Effects 0.000 claims description 7
- 239000004743 Polypropylene Substances 0.000 claims description 5
- 229920001748 polybutylene Polymers 0.000 claims description 5
- 229920006289 polycarbonate film Polymers 0.000 claims description 5
- 229920006267 polyester film Polymers 0.000 claims description 5
- 229920001155 polypropylene Polymers 0.000 claims description 5
- 238000005240 physical vapour deposition Methods 0.000 claims description 4
- 229930195733 hydrocarbon Natural products 0.000 claims description 3
- 150000002430 hydrocarbons Chemical class 0.000 claims description 3
- 229920001296 polysiloxane Polymers 0.000 claims description 3
- 239000012530 fluid Substances 0.000 abstract description 80
- 238000004451 qualitative analysis Methods 0.000 abstract description 3
- 238000004445 quantitative analysis Methods 0.000 abstract description 3
- 239000010410 layer Substances 0.000 description 124
- 239000000523 sample Substances 0.000 description 120
- 239000000123 paper Substances 0.000 description 105
- 239000010408 film Substances 0.000 description 79
- 239000000976 ink Substances 0.000 description 63
- 238000012360 testing method Methods 0.000 description 35
- 238000003556 assay Methods 0.000 description 30
- 239000000427 antigen Substances 0.000 description 23
- 108091007433 antigens Proteins 0.000 description 23
- 102000036639 antigens Human genes 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 238000004806 packaging method and process Methods 0.000 description 20
- 239000007788 liquid Substances 0.000 description 15
- 230000009471 action Effects 0.000 description 13
- 238000007906 compression Methods 0.000 description 13
- 239000000853 adhesive Substances 0.000 description 12
- 230000001070 adhesive effect Effects 0.000 description 12
- 230000006835 compression Effects 0.000 description 12
- 230000008859 change Effects 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 238000004891 communication Methods 0.000 description 8
- 238000003018 immunoassay Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 238000012546 transfer Methods 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 210000001124 body fluid Anatomy 0.000 description 7
- 230000000670 limiting effect Effects 0.000 description 7
- 230000035699 permeability Effects 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 239000011230 binding agent Substances 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000009736 wetting Methods 0.000 description 6
- 238000002965 ELISA Methods 0.000 description 5
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000004888 barrier function Effects 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000000717 retained effect Effects 0.000 description 5
- 239000012488 sample solution Substances 0.000 description 5
- 238000003848 UV Light-Curing Methods 0.000 description 4
- 239000012790 adhesive layer Substances 0.000 description 4
- 238000007774 anilox coating Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 238000003466 welding Methods 0.000 description 4
- 229920002799 BoPET Polymers 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000027455 binding Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000002967 competitive immunoassay Methods 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 2
- 241000711573 Coronaviridae Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000002820 assay format Methods 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000007398 colorimetric assay Methods 0.000 description 2
- 239000007822 coupling agent Substances 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 238000001723 curing Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000000059 patterning Methods 0.000 description 2
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000004834 spray adhesive Substances 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 238000011179 visual inspection Methods 0.000 description 2
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
- HSTOKWSFWGCZMH-UHFFFAOYSA-N 3,3'-diaminobenzidine Chemical compound C1=C(N)C(N)=CC=C1C1=CC=C(N)C(N)=C1 HSTOKWSFWGCZMH-UHFFFAOYSA-N 0.000 description 1
- QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241001225321 Aspergillus fumigatus Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- 241000589969 Borreliella burgdorferi Species 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000025721 COVID-19 Diseases 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 241000606153 Chlamydia trachomatis Species 0.000 description 1
- 241000222290 Cladosporium Species 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- 241000223205 Coccidioides immitis Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000709687 Coxsackievirus Species 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 206010059875 Device ineffective Diseases 0.000 description 1
- 241001115402 Ebolavirus Species 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000224467 Giardia intestinalis Species 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
- 101000618467 Hypocrea jecorina (strain ATCC 56765 / BCRC 32924 / NRRL 11460 / Rut C-30) Endo-1,4-beta-xylanase 2 Proteins 0.000 description 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
- 241000589242 Legionella pneumophila Species 0.000 description 1
- 241001137872 Leishmania sp. Species 0.000 description 1
- 241000186779 Listeria monocytogenes Species 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 241000127282 Middle East respiratory syndrome-related coronavirus Species 0.000 description 1
- 241000186362 Mycobacterium leprae Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 208000010195 Onychomycosis Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 241001442539 Plasmodium sp. Species 0.000 description 1
- 241000233872 Pneumocystis carinii Species 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 241000606726 Rickettsia typhi Species 0.000 description 1
- 241000315672 SARS coronavirus Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 241000194049 Streptococcus equinus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 201000010618 Tinea cruris Diseases 0.000 description 1
- 241000589884 Treponema pallidum Species 0.000 description 1
- 241000220979 Trichomonas sp. Species 0.000 description 1
- 241000223093 Trypanosoma sp. Species 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- CKUAXEQHGKSLHN-UHFFFAOYSA-N [C].[N] Chemical compound [C].[N] CKUAXEQHGKSLHN-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- ZTOJFFHGPLIVKC-CLFAGFIQSA-N abts Chemical compound S/1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-CLFAGFIQSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 229940091771 aspergillus fumigatus Drugs 0.000 description 1
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000337 buffer salt Substances 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 229940085435 giardia lamblia Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- ZBKIUFWVEIBQRT-UHFFFAOYSA-N gold(1+) Chemical compound [Au+] ZBKIUFWVEIBQRT-UHFFFAOYSA-N 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 201000010284 hepatitis E Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229940115932 legionella pneumophila Drugs 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- CSJDCSCTVDEHRN-UHFFFAOYSA-N methane;molecular oxygen Chemical compound C.O=O CSJDCSCTVDEHRN-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000002991 molded plastic Substances 0.000 description 1
- 229920000344 molecularly imprinted polymer Polymers 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 239000011049 pearl Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- UAKCMIIOSJFOTD-UHFFFAOYSA-M sodium;3-oxobutanoate Chemical compound [Na+].CC(=O)CC([O-])=O UAKCMIIOSJFOTD-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 238000002076 thermal analysis method Methods 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 201000005882 tinea unguium Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 239000006226 wash reagent Substances 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502707—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the manufacture of the container or its components
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/02—Adapting objects or devices to another
- B01L2200/025—Align devices or objects to ensure defined positions relative to each other
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0874—Three dimensional network
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0887—Laminated structure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/12—Specific details about materials
- B01L2300/126—Paper
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/16—Surface properties and coatings
- B01L2300/161—Control and use of surface tension forces, e.g. hydrophobic, hydrophilic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0406—Moving fluids with specific forces or mechanical means specific forces capillary forces
Definitions
- the present disclosure relates to diagnostic devices and more particularly to edge-sealed porous substrate -based (e.g., paper-based) medical and food safety diagnostic devices and methods of making the same.
- edge-sealed porous substrate -based e.g., paper-based
- a porous substrate including a reagent selected to rapidly perform quantitative or qualitative analysis of a fluid sample such as, for example, a bodily fluid, an industrial fluid, food samples or water, in the field when laboratory facilities are not available or easily accessed for sample analysis.
- a paper- based diagnostic device includes a colorimetric immunoassay reagent with a color change as a readout, and the color change readout can be detected visually or with a machine to provide a rapid, low-cost diagnosis of the presence of an infectious disease.
- analytes in a sample can be rapidly detected using the diagnostic devices include viral antigens, bacterial antigens, fungal antigens, parasitic antigens, cancer antigens, metabolic markers, and combinations thereof.
- antibodies acting as binding proteins can be used to capture disease-relevant biomarkers from the patient sample, and then produce a visible diagnostic signal resulting from the binding event.
- the diagnostic devices include multiple layers of a porous material disposed in planes parallel to one another and in face-to-face contact.
- the various layers of the diagnostic device include fluid impermeable hydrophobic regions and hydrophilic water absorbent regions arranged to provide a sample flow path configured such that a fluid sample can wick or flow from one layer to another.
- At least some of the layers include reagents, buffer salts, analytes (for example antigens) and binders (for example, antibodies) selected to perform a multiplexed assay.
- U.S, 8,628,729 describes a method for making paper-based devices that includes building fluid- impermeable areas in paper.
- U.S. 9,669,638 describe ink-jet printing methods for making hydrophobic areas in otherwise hydrophilic media.
- U.S. 9,597,684 describes other methods for forming liquid- impermeable barriers in hydrophilic media.
- the present disclosure is directed to inexpensive, easy to use diagnostic devices for quantitative or qualitative analysis of a sample fluid including an analyte.
- Suitable sample fluids include, but are not limited to, body fluids (e.g., blood, sputum, saliva, or urine), industrial fluids, water samples, and the like.
- the diagnostic device includes at least two substantially planar portions, each planar portion made from a hydrophilic material such as paper. The planar portions are stacked on each other and each occupy a different and substantially parallel plane to form a three- dimensional porous structure.
- a diagnostic device including multiple planar regions of a porous substrate, optionally having different reagents or different patterns of hydrophobic and hydrophilic regions, multiple layers must be individually produced, accurately stacked and aligned to provide the sample flow path, and adhered together in order to maintain the continuity of the sample flow path and form an operable stack.
- manufacturing costs have limited deployment of these types of diagnostic devices, particularly to resource-limited settings such as developing nations.
- porous substrate-based (e.g. , paper-based) diagnostic device is made from multiple layers of the porous substrate (e.g. , paper)
- intimate contact between the porous substrate (e.g., paper) layers is critical for device performance. If a gap is formed between layers of paper, testing fluid will flow laterally in that gap, in addition to normal flow across the layers of paper. When the testing liquid flows laterally in the gaps instead of normal to the layers of paper, it will not react with reagents deposited within the pores of the paper layers. In addition, the time that it takes for liquid to flow a given distance through the layers becomes unpredictable.
- a porous substrate-based diagnostic device is formed by folding the porous substrate (e.g., paper)
- the folds function like springs that push the porous substrate (e.g., paper) layers apart.
- Methods need to be developed to manage that spring action and ensure that the multilayer porous substrate (e.g., paper) stack is compressed to provide intimate contact between the various layers in the multilayer porous substrate (e.g., paper) stack.
- This disclosure describes multiple methods for maintaining a porous substrate stack (e.g., a paper substrate stack) in a multi-layer porous substrate-based (e.g., paper-based) diagnostic device without significant gaps between the layers of the porous substrate (e.g., paper).
- the gap between the layers of a multilayer porous substrate stack is considered significant when the thickness of the fully compressed multilayer porous substrate stack is less than 95% of the thickness of the uncompressed multilayer porous substrate stack.
- an uncompressed multilayer porous substrate stack with ten layers of the porous substrate, where each layer of porous substrate has a porosity of 30% and a thickness of 180 micrometers would theoretically have an uncompressed thickness of 1800 micrometers and a fully compressed thickness of 1,260 micrometers, corresponding to a 70% air gap or approximately a 60 micrometers-thick air layer for each porous substrate layer in the multilayer porous substrate stack.
- the present disclosure describes diagnostic devices including a first metallic or (co)polymeric substrate, a second metallic or (co)polymeric substrate opposite the first (co)polymeric substrate, an elongate substantially planar porous substrate positioned between the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, and a plurality of edge seals formed between the first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate such that the first and the second metallic or (co)polymeric substrates together substantially surround and encapsulate the porous substrate.
- An optional compressible layer is preferably positioned between at least one of the first metallic or (co)polymeric substrate and the porous substrate and/or the second metallic or (co)polymeric substrate and the porous substrate.
- a second portion of the porous substrate lies in a second plane with respect to the folded region, wherein the second plane is substantially parallel to the first plane.
- the second portion of the porous substrate includes a second hydrophilic region and a second hydrophobic region comprising a second low surface energy (co)polymeric material, which may be the same or different from the first low surface energy (co)polymeric material, extending from a first major surface of the second portion of the porous substrate to second major surface of the second portion of the porous substrate.
- the second hydrophobic region includes an arrangement of interconnected open pores providing at least one uninterrupted path extending from the first major surface of the second portion of the porous substrate to the second major surface of the second portion of the porous substrate.
- a reagent is positioned along the sample flow path.
- the reagent is selected to detect at least one of a presence, an absence or a concentration of an analyte present in a sample applied to the diagnostic device.
- the present disclosure describes a diagnostic device including a first (co)polymeric substrate, a second (co)polymeric substrate opposite the first (co)polymeric substrate, an elongate substantially planar porous substrate comprising a multiplicity of fibers, and a plurality of edge seals formed between the first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate.
- the porous substrate is positioned between the first (co)polymeric substrate and the second (co)polymeric substrate such that the first and the second (co)polymeric substrates together substantially surround and encapsulate the porous substrate.
- An optional compressible layer is preferably positioned between at least one of the first metallic or (co)polymeric substrate and the porous substrate and/or the second metallic or (co)polymeric substrate and the porous substrate.
- the porous substrate includes a multiplicity of folded regions between a first end and a second end of the porous substrate.
- the multiplicity of folded regions divide the planar porous fibrous substrate into a multilayer stack of overlying substantially planar panels, wherein each of the panels in the multilayer stack occupies a different substantially parallel plane.
- a connective region is configured to attach adjacent panels to each other.
- the planar panels include at least one hydrophobic region including fibers coated with a hydrophobic low surface energy (co)polymeric ink such that open areas remain between the fibers, the open areas between the fibers providing at least one uninterrupted open flow path between a first major surface of the panel and a second major surface of the panel, and at least one hydrophilic region.
- the hydrophobic regions and hydrophilic regions in adjacent panels of the stack are aligned with each other to provide the sample flow path between the hydrophilic regions thereof along a direction normal to the first plane and the second plane such that the sample contacts the reagent disposed in the flow path to provide an indication of at least one of the presence, absence or concentration of the analyte in the sample.
- a reagent is positioned along the sample flow path.
- the reagent is selected to detect at least one of a presence, an absence or a concentration of an analyte present in a sample applied to the diagnostic device.
- the plurality of edge seals comprises at least one cured monomer, oligomer, or (co)polymer, or a combination thereof.
- the plurality of edge seals comprise a first heat-sealable (co)polymeric film and a second heat-sealable (co)polymeric film, wherein a portion of each heat- sealable (co)polymeric film overlays an opposing major surface of the porous substrate, further wherein the first and second heat-sealable (co)polymeric films are bonded to each other at a plurality of each heat- sealable (co)polymeric film’s edges which do not overlap the porous substrate.
- the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate further comprise at least one access port created by removing a portion of at least one of the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, optionally in a region which overlaps a first hydrophilic region of the porous substrate.
- the disclosed diagnostic devices are particularly well adapted to conduct immunoassays, such as sandwich or competitive immunoassays, although they may be readily adapted to execute assay formats including steps such as, for example, filtration, multiple incubations with different reagents or combinations of reagents, serial or timed addition of reagents, various incubation times, washing, and the like.
- the diagnostic devices are particularly effective for executing colorimetric assays, e.g., immunoassays with a color change as a readout, and are easily adapted to execute multiple assays simultaneously. They are extremely sensitive, simple to manufacture, inexpensive, and versatile.
- the present disclosure is directed to a method of making a diagnostic device, the method including:
- a hydrophobic hardenable (co)polymeric ink composition to an elongate web of a fibrous material, wherein the hydrophobic hardenable (co)polymeric ink composition is applied in a plurality of adjacent web regions extending from a first edge of the web to a second edge of the web, wherein each web region is separated from adjacent web regions by a border region; each and wherein each web region includes a hydrophobic area including the hydrophobic (co)polymeric ink composition, a hydrophilic area substantially free of the hydrophobic (co)polymeric ink composition;
- the method further includes providing an optional compressible layer preferably positioned between at least one of the first metallic or (co)polymeric substrate and the porous substrate and/or the second metallic or (co)polymeric substrate and the porous substrate.
- the plurality of edge seals around at least a perimeter of the folded web of fibrous material comprise stitching, needle punching, stapling, adhesive bonding, heat sealing, shrink-wrapping, ultrasonic bonding, or a combination thereof.
- the plurality of edge seals comprise at least one heat-sealable (co)polymeric film, optionally wherein the plurality of edge seals comprise a first heat-sealable (co)polymeric film and a second heat-sealable (co)polymeric film, wherein a portion of each heat-sealable (co)polymeric film overlays opposed major surfaces of the folded web of fibrous material, further wherein the first and second heat-sealable (co)polymeric films are bonded to each other at a plurality of each heat-sealable (co)polymeric film’s edges which do not overlap the folded web of fibrous material.
- the first and second (co)polymeric substrate heat-sealable (co)polymeric films are independently selected from the group consisting of polyethylene films, polypropylene films, polybutylene films, polycarbonate films and polyester films.
- the method further includes creating at least one access port in the diagnostic device by removing a portion of at least one of the first metallic or (co)polymeric film or the second metallic or (co)polymeric film in a region which overlaps the first hydrophilic region of the porous substrate.
- the elongate porous substrate is chosen from paper, nonwoven materials, (co)polymeric films, and combinations thereof.
- the ink composition is applied to the elongate web of porous substrate by at least one of printing, coating, physical vapor deposition, and combinations thereof.
- the method further includes disposing a reagent in at least one of the hydrophilic areas along the flow path, wherein the reagent is selected to provide an indication of at least one of a presence, an absence, and a concentration of an analyte in the sample.
- exemplary embodiments of the disclosure Various unexpected results and advantages are obtained in exemplary embodiments of the disclosure.
- One such advantage of exemplary embodiments of the present disclosure is that the reliability and reproducibility of the diagnostic device is improved by providing a controlled, repeatable compressive force to the multilayer paper stack to eliminate air gaps which can adversely affect both the time required to obtain a test result and the dependability and repeatability of the test result.
- An additional advantage of exemplary embodiments is to provide an adhesive-free assembly method for the diagnostic device, as some adhesives can penetrate into the pores of the multilayer paper stack and inhibit or prevent the wicking of the test sample through the multilayer paper stack in either a vertical or lateral direction.
- Another advantage of exemplary embodiments is to enable a high speed, roll-to-roll continuous production process for the paper substrate and, in certain embodiments, even the paper-based diagnostic device.
- a further advantage of exemplary embodiments is the ability to achieve a fully automated assembly process for the paper-based diagnostic device.
- Embodiment A A diagnostic device, comprising: an elongate substantially planar porous substrate with a first end and a second end positioned between a first metallic or (co)polymeric substrate and a second metallic or (co)polymeric substrate such that the first and the second metallic or (co)polymeric substrates substantially surround and encapsulate the porous substrate, wherein the porous substrate comprises at least one folded region between the first end and the second end; a plurality of edge seals formed between the first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate; and optionally a compressible layer positioned between the first metallic or (co)polymeric substrate and the porous substrate and/or a compressible layer positioned between the second metallic or (co)polymeric substrate and the porous substrate; the diagnostic device optionally further comprising: a first portion of the porous substrate that lies in a first plane with respect to the folded region, wherein the first portion of the porous substrate comprises a first hydrophobic
- Embodiment B A diagnostic device, comprising: an elongate substantially planar porous substrate comprising a plurality of fibers, wherein a first end and a second end of the porous substrate is positioned between a first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate such that the first and the second (co)polymeric substrates substantially surround and encapsulate the porous substrate, wherein the porous substrate comprises; a plurality of folded regions between the first end and the second end, the plurality of folded regions dividing the planar porous fibrous substrate into a stack of overlying substantially planar panels, wherein each of the panels in the stack occupies a different substantially parallel plane; a plurality of edge seals formed between the first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate; and optionally a compressible layer positioned between the first metallic or (co)polymeric substrate and the porous substrate and/or a compressible layer positioned between the second
- Embodiment C The diagnostic device of Embodiment A or B, wherein the plurality of edge seals comprises at least one cured monomer, oligomer, or (co)polymer, or a combination thereof.
- Embodiment D The diagnostic device of any preceding Embodiment, wherein the plurality of edge seals comprise a first heat-sealable (co)polymeric film and a second heat-sealable (co)polymeric film, wherein a portion of each heat-sealable (co)polymeric film overlays an opposing major surface of the porous substrate, further wherein the first and second heat-sealable (co)polymeric films are bonded to each other at a plurality of each heat-sealable (co)polymeric film’s edges which do not overlap the porous substrate.
- Embodiment E The diagnostic device of any preceding Embodiment, wherein the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate further comprise at least one access port created by removing a portion of at least one of the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, optionally in a region which overlaps the first hydrophilic region of the porous substrate.
- Embodiment F The diagnostic device of any preceding Embodiment, wherein the elongate porous substrate is chosen from paper, nonwoven materials, (co)polymeric films, and combinations thereof.
- Embodiment G The diagnostic device of Embodiment F, wherein the elongate porous substrate comprises paper.
- Embodiment H The diagnostic device of any preceding Embodiment, wherein the optional hydrophobic regions substantially surround the hydrophilic regions.
- Embodiment I The diagnostic device of Embodiments A, C, D, E, G, or H, wherein the optional first and second low surface energy (co)polymeric materials each comprise a radiation curable (co)polymeric ink.
- Embodiment J The diagnostic device of Embodiments A, C, D, E, G, H or I, wherein the optional first and second low surface energy (co)polymeric materials comprise monomers, oligomers, or (co)polymers chosen from fluorocarbons, silicones, or hydrocarbons.
- Embodiment K The diagnostic device of Embodiments A, C, D, E, G, H, I or J, wherein the optional first and second low surface energy (co)polymeric materials comprise a hydrophobic ink with a surface energy lower than 35 dynes/cm.
- Embodiment L The diagnostic device of Embodiments B, C, D, E, G or H, wherein the optional at least one connective region occupies a periphery of the panels and substantially surrounds the optional hydrophobic regions.
- Embodiment M A method of making a diagnostic device, the method comprising: applying a hydrophobic hardenable (co)polymeric ink composition to an elongate web of a fibrous material, wherein the hydrophobic hardenable (co)polymeric ink composition is applied in a plurality of adjacent web regions extending from a first edge of the web to a second edge of the web, wherein each web region is separated from adjacent web regions by a border region; each and wherein each web region comprises: a hydrophobic area comprising the hydrophobic (co)polymeric ink composition, a hydrophilic area substantially free of the hydrophobic (co)polymeric ink composition, and at least partially hardening the hardenable (co)polymeric ink composition in the hydrophobic areas of each web region to provide a hydrophobic ink on fibers of the fibrous material and open areas between the fibers, the open areas between the fibers providing at least one uninterrupted open ink-free flow path between a first major surface of the web and
- Embodiment N The method of Embodiment M, wherein forming the plurality of edge seals around at least a portion of the perimeter of the folded web of fibrous material comprises stitching, needle punching, stapling, adhesive bonding, heat-sealing, shrink-wrapping, ultrasonic bonding, or a combination thereof.
- Embodiment O The method of Embodiment M or N, wherein the plurality of edge seals comprise at least one heat-sealable (co)polymeric film, optionally wherein the plurality of edge seals comprise a first heat-sealable (co)polymeric film and a second heat-sealable (co)polymeric film, wherein a portion of each heat-sealable (co)polymeric film overlays opposed major surfaces of the folded web of fibrous material, further wherein the first and second heat-sealable (co)polymeric films are bonded to each other at a plurality of each heat-sealable (co)polymeric film’s edges which do not overlap the folded web of fibrous material.
- Embodiment P The method of Embodiment M, N or O, wherein the first and second
- (co)polymeric substrate heat-sealable (co)polymeric films are independently selected from the group consisting of polyethylene films, polypropylene films, polybutylene films, polycarbonate films and polyester films.
- Embodiment Q The method of Embodiment M, N, O or P, further comprising creating at least one access port in the diagnostic device by removing a portion of at least one of the first metallic or (co)polymeric film or the second metallic or (co)polymeric film in a region which overlaps the first hydrophilic region of the porous substrate.
- Embodiment R The method of Embodiment M, N, O, P or Q, wherein the elongate porous substrate is chosen from paper, nonwoven materials, (co)polymeric films, and combinations thereof.
- Embodiment S The method of Embodiment M, N, O, P, Q or R, wherein the ink composition is applied to the elongate web of porous substrate by at least one of printing, coating, physical vapor deposition, and combinations thereof.
- Embodiment T The method of Embodiment M, N, O, P, Q, R or S, further comprising disposing a reagent in at least one of the hydrophilic areas along the flow path, wherein the reagent is selected to provide an indication of at least one of a presence, an absence, and a concentration of an analyte in the sample.
- FIG. 1 is a schematic side view of a porous substrate-based (e.g, paper-based) diagnostic device prior to ultrasonic bonding according to an embodiment of the present disclosure.
- a porous substrate-based diagnostic device prior to ultrasonic bonding according to an embodiment of the present disclosure.
- FIG. 2A is a schematic top view of a porous substrate-based (e.g. , paper-based) diagnostic device after edge-sealing according to an embodiment of the present disclosure.
- a porous substrate-based e.g. , paper-based
- FIG. 2B is a schematic side view of the porous substrate-based (e.g., paper-based) diagnostic device after edge-sealing according to the embodiment shown in FIG. 2A of the present disclosure.
- FIG. 3A is a schematic top view of a porous substrate-based (e.g. , paper-based) diagnostic device after edge-sealing according to an alternative embodiment of the present disclosure
- FIG. 3B is a schematic side view of a porous substrate-based (e.g., paper-based) diagnostic device after edge-sealing according to the embodiment shown in FIG. 3 A of the present disclosure.
- FIG. 4A is a schematic top view of a porous substrate-based (e.g.
- FIG. 4B is a schematic side view of a porous substrate-based (e.g., paper-based) diagnostic device after edge-sealing according to the embodiment shown in FIG. 4A of the present disclosure.
- like reference numerals indicate like elements. While the above-identified drawings, which may not be drawn to scale, sets forth various embodiments of the present disclosure, other embodiments are also contemplated, as noted in the Detailed Description. In all cases, this disclosure describes the presently disclosed disclosure by way of representation of exemplary embodiments and not by express limitations. It should be understood that numerous other modifications and embodiments can be devised by those skilled in the art, which fall within the scope and spirit of this disclosure.
- (co)polymer” and “(co)polymer” include homopolymers and copolymers, such as homopolymers or copolymers that may be formed in a miscible blend, e.g., by coextrusion or by reaction, including, e.g., transesterification.
- copolymer includes both random and block copolymers.
- the term “coupling agent” means a compound which provides a chemical bond between two dissimilar materials, usually an inorganic and an organic material. Coupling agents are typically multi - functional molecules or oligomers which can act to effect crosslinking during chemical reactions, for example, a chemical reaction such as free radical polymerization to form a (co)polymer.
- layer refers to a single stratum within a multi-strata (multilayer) assembly.
- encapsulate or “encapsulated” means enclosed or encased within.
- (meth)acryl or “(meth)acrylate” with respect to a monomer, oligomer, (co)polymer or compound means a vinyl-functional alkyl ester formed as the reaction product of an alcohol with an acrylic or a methacrylic acid.
- crosslinked (co)polymer refers to a (co)polymer whose (co)polymer chains are joined together by covalent chemical bonds, usually via crosslinking molecules or groups, to form a network (co)polymer.
- a crosslinked (co)polymer is generally characterized by insolubility but may be swellable in the presence of an appropriate solvent.
- cure refers to a process that causes a chemical change, e.g., a reaction that creates a covalent bond to solidify a multilayer film layer or increase its viscosity.
- cured (co)polymer includes both crosslinked and uncrosslinked polymers.
- T g glass transition temperature of a (co)polymer when evaluated in bulk rather than in a thin film form.
- the bulk form T g can usually be estimated with reasonable accuracy.
- Bulk form T g values usually are determined by evaluating the rate of heat flow vs. temperature using differential scanning calorimetry (DSC) to determine the onset of segmental mobility for the (co)polymer and the inflection point (usually a second-order transition) at which the (co)polymer can be said to change from a glassy to a rubbery state.
- DSC differential scanning calorimetry
- Bulk form T g values can also be estimated using a dynamic mechanical thermal analysis (DMTA) technique, which measures the change in modulus of the (co)polymer as a function of temperature and frequency of vibration of a test sample.
- DMTA dynamic mechanical thermal analysis
- joining with reference to a particular layer means joined with or attached to another layer, in a position wherein the two layers are either next to (i.e.. adjacent to) and directly contacting each other, or contiguous with each other but not in direct contact (i.e.. there are one or more additional layers intervening between the layers).
- orientation By using terms of orientation such as “atop”, “on”, “over,” “covering”, “uppermost”, “underlying” and the like for the location of various elements in the disclosed coated articles, we refer to the relative position of an element with respect to a horizontally-disposed, upwardly-facing substrate. However, unless otherwise indicated, it is not intended that the substrate or articles should have any particular orientation in space during or after manufacture.
- a viscosity of “about” 1 Pa-sec refers to a viscosity from 0.95 to 1.05 Pa- sec, but also expressly includes a viscosity of exactly 1 Pa-sec.
- a perimeter that is “approximately square” is intended to describe a geometric shape having four lateral edges in which each lateral edge has a length which is from 99% to 101% of the length of any other lateral edge, but which also includes a geometric shape in which each lateral edge has exactly the same length.
- a substrate that is “substantially” transparent refers to a substrate that transmits more radiation (e.g. visible light) than it fails to transmit (e.g. absorbs and reflects).
- a substrate that transmits more than 50% of the visible light incident upon its surface is substantially transparent, but a substrate that transmits 50% or less of the visible light incident upon its surface is not substantially transparent.
- the present disclosure describes diagnostic devices including a first metallic or (co)polymeric substrate, a second metallic or (co)polymeric substrate opposite the first (co)polymeric substrate, an elongate substantially planar porous substrate positioned between the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, and a plurality of edge seals formed between the first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate such that the first and the second metallic or (co)polymeric substrates together substantially surround and encapsulate the porous substrate.
- the present disclosure describes a diagnostic device including a first (co)polymeric substrate, a second (co)polymeric substrate opposite the first (co)polymeric substrate, an elongate substantially planar porous substrate comprising a multiplicity of fibers positioned between the first (co)polymeric substrate and the second (co)polymeric substrate, and a plurality of edge seals formed between the first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate such that the first and the second metallic or (co)polymeric substrates together substantially surround and encapsulate the porous substrate.
- an optional compressible layer is preferably positioned between at least one of the first metallic or (co)polymeric substrate and the porous substrate and/or the second metallic or (co)polymeric substrate and the porous substrate.
- a diagnostics device is made from multiple layers (e.g., paper)
- intimate contact between layers is important for reproducible device performance.
- the testing fluid may flow in that gap, in addition to flowing within the porous structure of the porous substrate.
- liquid flows in the gaps instead of within a porous layer of the porous substrate, it may not react with reagents deposited in that layer.
- liquid flow in the device may become unpredictable or non-reproducible.
- the optional first compressible layer may be advantageously applied to compress the stacked layers tightly against each other to eliminate or mitigate a significant gap between the adjacent porous substrate layers or portions thereof.
- a gap is considered significant when the gap is greater than 75 micrometers, greater than 50 micrometers, greater than 25 micrometers, greater than 10 micrometers, greater than 5 micrometers, greater than 2 micrometers, greater than one micrometer and the like.
- a gap is considered significant when the fraction of fluid sample flowing into the gap is more than 20 weight %, more than 10 weight %, 5 weight %, 2 weight %, 1 weight % and the like.
- Suitable metallic or (co)polymeric substrates, porous substrates, optional compressible layers and diagnostic devices are described in co-pending U.S. Prov. Patent Application 63/003,169, fded March 31, 2020 and titled “DIAGNOSTIC DEVICE”; co-pending U.S. Prov. Patent Application 63/164,144, fded March 22, 2021 and titled “DIAGNOSTIC DEVICE”; co-pending U.S. Prov. Patent Application 63/200,871, fded March 31, 2021 and titled “UUTRASONICAUUY -BONDED POROUS SUBSTRATE DIAGNOSTIC DEVICES AND METHODS OF MAKING SAME”; co-pending U.S. Prov.
- the plurality of edge seals comprises at least one cured monomer, oligomer, or (co)polymer, or a combination thereof.
- the plurality of edge seals comprise a first heat-sealable (co)polymeric film and a second heat-sealable (co)polymeric film, wherein a portion of each heat-sealable (co)polymeric film overlays an opposing major surface of the porous substrate, further wherein the first and second heat-sealable (co)polymeric films are bonded to each other at a plurality of each heat-sealable (co)polymeric film’s edges which do not overlap the porous substrate.
- the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate further comprise at least one access port created by removing a portion of at least one of the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, optionally in a region which overlaps a first hydrophilic region of the porous substrate.
- the elongate porous substrate is chosen from paper, nonwoven materials, (co)polymeric films, and combinations thereof. It is presently preferred that the elongate porous substrate includes paper.
- the disclosed diagnostic devices are particularly well adapted to conduct immunoassays, such as sandwich or competitive immunoassays, although they may be readily adapted to execute assay formats including steps such as, for example, filtration, multiple incubations with different .or combinations of reagents, serial or timed addition of reagents, various incubation times, washing, and the like.
- the diagnostic devices are particularly effective for executing colorimetric assays, e.g., immunoassays with a color change as a readout, and are easily adapted to execute multiple assays simultaneously. They are extremely sensitive, simple to manufacture, inexpensive, and versatile.
- FIG. 1 a porous substrate -based (e.g., paper-based) diagnostic device 100 according to an embodiment of the present disclosure is shown prior to compression and edge-sealing.
- the device 100 comprises a porous substrate 102, which may be a paper web, having a plurality of substantially planar opposed faces 102 (a-e) and a plurality of edges 104 for folding the porous substrate 102 upon itself to form a multilayer porous substrate (e.g., paper) stack.
- a porous substrate 102 which may be a paper web, having a plurality of substantially planar opposed faces 102 (a-e) and a plurality of edges 104 for folding the porous substrate 102 upon itself to form a multilayer porous substrate (e.g., paper) stack.
- FIG. 2A is a schematic top view of a porous substrate-based (e.g. , paper-based) diagnostic device 200 after edge-sealing according to an embodiment of the present disclosure.
- FIG. 2B is a schematic side view of the porous substrate-based (e.g., paper-based) diagnostic device 200 of FIG. 2A after edge sealing.
- a porous substrate (e.g., paper) 202 is shown folded upon itself at a plurality of edges 204 to form a multilayer porous substrate (e.g, paper) stack.
- a plurality of edge seals 208 is formed between first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate.
- the plurality of edge seals 208 may be formed by adhesive bonding as shown in FIG. 2A, or by stitching, needle punching, stapling, heat-sealing, shrink-wrapping, ultrasonic bonding, or a combination thereof.
- a first access port 206a optionally may be created by removing a portion of at least one of the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, optionally in a region which overlaps a first hydrophilic region of the porous substrate.
- a second access port 206b optionally may be created by removing a portion of at least one of the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, optionally in a region which overlaps a first hydrophilic region of the porous substrate.
- the second access port 206b is preferably positioned on the same side of the porous substrate 202 as the first access port 206a as shown in FIG. 2A.
- the second access port 206b is preferably positioned on the opposite side of the porous substrate 202 as the first access port 206a.
- FIG. 3A is a schematic top view of a porous substrate-based (e.g. , paper-based) diagnostic device 300 after edge-sealing according to an alternative embodiment of the present disclosure.
- FIG. 3B is a schematic side view of the porous substrate-based (e.g., paper-based) diagnostic device 300 of FIG. 3A after edge-sealing according to an alternative embodiment of the present disclosure.
- a porous substrate (e.g., paper) 302 is shown folded upon itself at a plurality of edges 304 to form a multilayer porous substrate (e.g, paper) stack.
- a plurality of edge seals 308 is formed between first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate.
- the plurality of edge seals 308 may be formed by stitching as shown in FIG. 3 A, or by needle punching, stapling, adhesive bonding, heat-sealing, shrink-wrapping, ultrasonic bonding, or a combination thereof.
- a first access port 306a optionally may be created by removing a portion of at least one of the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, optionally in a region which overlaps a first hydrophilic region of the porous substrate.
- a second access port 306b optionally may be created by removing a portion of at least one of the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, optionally in a region which overlaps a first hydrophilic region of the porous substrate.
- the second access port 306b is preferably positioned on the same side of the porous substrate 302 as the first access port 306a as shown in FIG. 3A.
- the second access port 306b is preferably positioned on the opposite side of the porous substrate 302 as the first access port 306a.
- FIG. 4A is a schematic top view of a porous substrate-based (e.g. , paper-based) diagnostic device 400 after edge-sealing according to another alternative embodiment of the present disclosure.
- FIG. 4B is a schematic side view of the porous substrate-based (e.g., paper-based) diagnostic device 400 of FIG. 4A after edge sealing according to another alternative embodiment of the present disclosure.
- a porous substrate (e.g., paper) 402 is shown folded upon itself at a plurality of edges 404 to form a multilayer porous substrate (e.g., paper) stack.
- a plurality of edge seals 408 is formed between first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate.
- the plurality of edge seals 408 may be formed by stapling as shown in FIG. 4A, or by stitching, needle punching, adhesive bonding, heat-sealing, shrink-wrapping, ultrasonic bonding, or a combination thereof.
- a first access port 406a optionally may be created by removing a portion of at least one of the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, optionally in a region which overlaps a first hydrophilic region of the porous substrate.
- a second access port 406b optionally may be created by removing a portion of at least one of the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, optionally in a region which overlaps a first hydrophilic region of the porous substrate.
- the second access port 406b is preferably positioned on the same side of the porous substrate 402 as the first access port 406a as shown in FIG. 4A.
- the second access port 406b is preferably positioned on the opposite side of the porous substrate 402 as the first access port 406a.
- the diagnostic device includes an elongate substantially planar hydrophilic porous substrate with a first (terminal) end, a second, opposed (terminal) end and at least one folded region between the first and the second ends.
- the folded region separates the hydrophilic substrate into a first sheet-like portion and a second sheet-like portion, each occupying a substantially parallel plane with respect to the folded region.
- the first porous substrate portion includes a first major surface and a second opposed major surface, while the second substrate portion includes a first major surface and a second opposed major surface.
- the first portion of the substrate and the second portion of the substrate overlie one another such that the respective major surfaces are adjacent to each other.
- the first substrate portion includes a first hydrophobic region and a first hydrophilic region
- the second substrate portion includes a second hydrophobic region and a second hydrophilic region.
- the fibers of the substrate in the hydrophobic regions have applied thereto a low surface energy polymeric material, and as such resist unassisted capillary fluid flow or wicking of a selected fluid, such as, for example, a sample fluid including, for example, an analyte, or a buffer or a wash solution, therethrough.
- a selected fluid such as, for example, a sample fluid including, for example, an analyte, or a buffer or a wash solution
- the shapes and sizes of the hydrophobic regions and the hydrophilic regions may vary widely depending on the intended use of the device. Any number of hydrophobic regions and hydrophilic regions may be used. However, since mass transfer of a fluid is proportional to the area of the wicking, varying the size of the hydrophilic regions or a coating pattern of the hydrophobic regions can be used to control mass transfer by wicking or capillary action across layers. For example, smaller hydrophilic regions will reduce mass transfer in direct relation to the reduced area of the substrate occupied by the hydrophilic regions.
- the web regions further include connective regions that surround the hydrophilic regions.
- the web region includes a patterned connective region of, for example, a pressure sensitive adhesive (PSA).
- PSA pressure sensitive adhesive
- the web may be folded along the separation regions to form a folded paper diagnostic device including overlying and substantially parallel panels.
- the connection regions come together to adhere and maintain registration of the panels, and the patterned connective region maintains the registration of the panels.
- the registration of the panels maintains alignment of the hydrophilic regions, which allows flow of sample fluid along a sample flow path through the hydrophilic regions.
- a diagnostic device in another embodiment, includes a sensor stack formed from a plurality of overlying substantially planar panels of a porous material. Each of the panels of the sensor stack include a hydrophobic region and a hydrophilic region. The hydrophilic regions are substantially aligned with each other to provide a sample flow path along the direction substantially normal to a first major surface to a second major surface thereof.
- the sample port formed by the hydrophilic region may optionally be colored to enhance contrast with the surrounding hydrophobic region and provide a guide for sample placement on the sensor stack.
- the hydrophilic region may also be colored to provide a color zone for reading the results of an assay performed with the sensor stack.
- the sensor stack is preferably overlain by a packaging layer.
- the packaging layer may vary widely, and can include, for example, a (co)polymeric film, a plastic molded cover, and the like.
- the packaging layer is an elastic polymeric film that contacts the first major surface of the sensor stack and compresses the sensor stack against the first major surface of the wicking layer. In some examples, such compression can improve wicking through the panels in the sensor stack.
- the packaging layer comprises at least on thermoplastic (co)polymeric film that contacts the first major surface of the sensor stack and compresses the sensor stack against the first major surface of the wicking layer.
- thermoplastic (co)polymeric film is a heat- sealable film.
- the packing layer may optionally include an access port aligned with the hydrophilic region of the sensor stack.
- the packaging layer may be attached to the first major surface of the wicking layer by a hinge.
- a diagnostic device in another exemplary embodiment, includes a sensor stack formed from a plurality of overlying substantially planar panels of a porous material such as, for example, paper.
- the panels may be discrete pieces of the porous material or may be a continuous web of porous material that is folded to form the individual panels.
- Each of the panels of the sensor stack may preferably include a hydrophobic region and a hydrophilic region. The hydrophilic regions are substantially aligned with each other to provide a sample flow path through the thickness of the sensor stack from a first major surface to a second major surface thereof.
- the hydrophilic region preferably provides an exposed sample port upon which a sample fluid is placed for analysis in the sensor stack, and as discussed in detail above the sample fluid moves through the panels in direction substantially normal to the first and second major surfaces by wicking or capillary action.
- An optional wicking layer includes a first major surface on the second major surface of the sensor stack, as well as an exposed second major surface.
- the optional wicking layer which in various embodiments is made of paper, woven materials, non-woven materials, glass fibers, and the like, helps to draw the sample fluid through the hydrophilic regions in the respective panels to increase the speed and efficiency of the capillary action process.
- the sample port formed by the hydrophilic region may optionally be colored to enhance contrast with the surrounding hydrophobic region and provide a guide for sample placement on the sensor stack.
- the hydrophilic region may also be colored to provide a color zone for reading for reading the results of an assay performed with the sensor stack.
- Another exemplary embodiment of an assay device includes a sensor stack formed from multiple overlying planar panels of a porous material.
- the sensor stack is formed from a single piece of porous material that is folded into multiple overlying planar panels. The sensor stack includes a first major surface and a second major surface.
- the panels of the sensor stack preferably include hydrophobic regions and hydrophilic regions, wherein the hydrophilic regions in each panel overlie and are aligned with each other to provide a sample flow path for migration of a fluid sample through the sensor stack from one panel to another along a direction substantially normal to the first an second major surfaces.
- the assay device may further include an optional wicking layer with a first major surface adjacent to the second major surface of the sensor stack, as well as an opposed second major surface.
- the wicking layer may be a single layer, or may include multiple sublayers.
- the sublayers of the wicking layer may optionally additionally be bonded together with adhesives, and in some examples the adhesives may be positioned to further enhance flow between the hydrophilic regions of the sensor stack, or to enhance the performance of lateral flow control features in the sublayers.
- the assay device further includes an outer packaging layer that overlies the cover layer, if present, or the first major surface of the sensor stack.
- the outer packaging layer is a polymeric tape construction with an adhesive layer that adheres to a surface of the backing layer.
- the outer packaging layer is an adhesive-free (co)polymeric film that is heat-sealed or ultrasonically welded to the surface of the backing layer.
- the outer packaging layer includes an “easy open” feature such as a tab or a strippable portion that can provide access to the hydrophilic regions of the sensor stack.
- the polymeric film of the outer packaging layer has elastic properties and exerts a compressive force on the sensor stack in a direction substantially normal to the first and second major surfaces of the porous stack to facilitate the optimal fluid transport rate and avoid lateral capillary flow between the stacked or folded panels thereof.
- the outer packaging layer includes apertures (not shown in FIG. 2A-4B) that overlie the apertures in the cover layer and the hydrophilic regions of the sensor stack. The overlying apertures in the cover layer and the outer packaging layer allow application of a sample fluid through the packaging layer and the cover layer onto the hydrophilic regions of the sensor stack.
- one or more optional adhesive layers may optionally be used to bond the wicking layer and the compression layer, or to bond the compression layer to the backing layer, or both.
- an optional arrangement of adhesive tabs on the second major surface of the sensor stack may be used to securely bond the sensor stack to the outer packaging layer.
- some or all of the adhesive layers or the adhesive tabs may be replaced with ultrasonic welds.
- the elongate hydrophilic substrate may be made from any porous, hydrophilic, adsorbent material capable of wicking a sample fluid by capillary action.
- the substrate is a paper product such as, for example, chromatographic paper, filter paper, and the like, but may also be chosen from woven or nonwoven fabrics, or from (co)polymer films such as, for example, nitrocellulose, cellulose acetate, polyesters, and polyurethane, and the like.
- the first and second hydrophobic regions may be formed by applying a desired pattern of a low surface energy polymeric material such as, for example, a polymeric ink composition that forms a low surface energy polymeric ink when cured, to the substrate.
- a low surface energy polymeric material such as, for example, a polymeric ink composition that forms a low surface energy polymeric ink when cured
- the hydrophobic regions thus resist absorption of a liquid applied to, for example, the hydrophilic region of the first substrate portion, and the liquid is passively transported via capillary action or wicking between the hydrophilic regions.
- the relative difference in absorption between the hydrophobic regions and the hydrophilic regions is a function of difference between the surface energy of the fibers in the hydrophilic regions for a selected liquid such as, for example, a sample fluid, a buffer, and the like, which are intended to flow between the substrate portions, and the surface energy of the fibers coated with an ink composition deposited or patterned onto the substrate and subsequently cured to form the low surface energy ink in the hydrophobic regions.
- the larger this difference the larger the resistivity to absorption of the selected fluid in the hydrophobic regions.
- the difference may also depend on, for example, the uniformity of ink coverage, the structure of the fibers, and the like.
- the surface energy of the fibers with the low surface energy hydrophobic ink applied thereto in the hydrophobic regions should be lower than the lowest value of the surface tension of the bodily fluid. Because bodily fluids have a range of surface tensions, the surface energy of the fibers in the hydrophobic regions should be at least 10 dynes/cm lower than the lowest surface tension of the bodily fluid, or at least 15 dynes/cm lower, or at least 20 dynes/cm lower, or even at least 30 dynes/cm lower.
- human urine has a minimum surface tension of about 55 dynes/cm
- human saliva has a surface tension of about 40 dynes/cm
- the hydrophobic regions 24, 28 surface energy of ink should have a surface tension of less than about 45 dynes/cm, or less than about 40 dynes/cm, or less than about 35 dynes/cm, or less than about 30 dynes/cm, or less than about 25 dynes/cm, or less than about 20 dynes/cm.
- Contact angles and wettability may be measured using the techniques described in, for example, CAPILLARITY AND WETTING PHENOMENA DROPS, BUBBLES, PEARLS, WAVES by Francoise Brochard-Wyart; David Quere, Hardcover; New York: Springer, September 12, 2003; WETTABILITY (SURFACTANT SCIENCE) by John Berg, ed., CRC Press; 1 edition, April 20, 1993, each of which are incorporated herein by reference in their entirety.
- the hydrophobic ink composition includes at least one polymerizable low surface energy monomer, oligomer, or (co)polymer that can provide a desired resistance to absorption of a selected liquid or sample fluid.
- This low surface energy monomer, oligomer, or (co)polymer can be a fluorocarbon, silicone, or hydrocarbon.
- the low surface energy monomer, oligomer, or (co)polymer is added to the formulation to reduce the surface energy of the cured hydrophobic coating to a wetting tension of from about 30 to less than about 38 mJ/m 2 as measured by ASTM D 2578-08.
- reagents may be disposed in, or in fluid communication with, the test area in hydrophilic regions of the diagnostic device to detect one or more analytes in a sample fluid.
- reagents include, but are not limited to, antibodies, nucleic acids, aptamers, molecularly-imprinted polymers, chemical receptors, proteins, peptides, inorganic compounds, and organic small molecules.
- one or more reagents may be adsorbed to one or more hydrophilic regions (non- covalently through non-specific interactions), or covalently (as esters, amides, imines, ethers, or through carbon-carbon, carbon-nitrogen, carbon-oxygen, or oxygen-nitrogen bonds).
- Any reagent needed in the assay may be provided within, or in a separate adsorbent layer in fluid communication with the test area within the hydrophilic regions and the sample flow path.
- Exemplary assay reagents include protein assay reagents, immunoassay reagents (e.g., ELISA reagents), glucose assay reagents, sodium acetoacetate assay reagents, sodium nitrite assay reagents, or a combination thereof.
- the diagnostic device may include, a blocking agent, enzyme substrate, specific binding reagent such as an antibody or sFv reagent, labeled binding agent, e.g., labeled antibody, may be disposed in the device within or in flow communication with one or more of the hydrophilic regions, or in a specific area thereof configured as a test area.
- Exemplary substrates for these enzymes include BCIP/NBT, 3,3',5,5'-Tetramethylbenzidine (TMB), 3,3'-Diaminobenzidine (DAB), and 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS), 4-methylumbelliferphosphoric acid, 3-(4-hydroxyphenyl)-propionic acid, or 4- methylumbellifer- -D-galactoside, or the like.
- TMB 3,3',5,5'-Tetramethylbenzidine
- DAB 3,3'-Diaminobenzidine
- ABTS 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid)
- 4-methylumbelliferphosphoric acid 3-(4-hydroxyphenyl)-propionic acid
- 4- methylumbellifer- -D-galactoside or the like.
- the reagent(s) develop color in one or more test areas along the sample path (including gradations from white to black) as an indication of the presence, absence or concentration of an analyte in a sample.
- a device may include many reagents disposed along the sample flow path, each of which can react with a different analyte to produce a detectable effect.
- the reagents may be sensitive to a predetermined concentration of a single analyte.
- the reagent may include a washing reagent, or plural wash reagents such as buffers or surfactant solutions, within or in fluid communication with a hydrophilic region or the sample flow path. Washing reagent(s) function to wash an analyte by removing unbound species within the hydrophilic regions.
- a suitable washing buffer may comprise phosphate buffered saline (PBS), detergent, surfactants, water, and salt.
- composition of the washing reagent will vary in accordance with the requirements of the specific assay such as, for example, the particular capture reagent and indicator reagent employed to determine the presence of a target analyte in a test sample, as well as the nature of the analyte itself.
- steps of a reaction using the devices disclosed herein may be washed as follows.
- defined hydrophilic regions do not contain a reagent
- water or buffer is then added to the hydrophilic regions of the device and the fluid passes through the device along the sample flow path to provide a washing step for the analytes in the fluid sample.
- washing steps can be used to remove unbound analyte or other components added for the detection of the presence of an analyte.
- the hydrophilic regions can include one or more test areas that can be used to perform one or more assays for the detection of multiple analytes in the sample fluid.
- One or more of the hydrophilic regions can be treated with reagents that respond to the presence of analytes in a sample fluid and provide an indicator of the presence of an analyte in the sample fluid.
- the detection of an analyte in the sample fluid is visible to the naked eye and can provide a color indicator of the presence of the analyte.
- indicators may include molecules that become colored in the presence of the analyte, change color in the presence of the analyte, or emit fluorescence, phosphorescence, or luminescence in the presence of the analyte.
- radiological, magnetic, optical, and/or electrical measurements can be used to determine the presence of proteins, antibodies, or other analytes in the sample flow path.
- the present disclosure describes methods of making diagnostic devices, the methods including:
- a hydrophobic hardenable (co)polymeric ink composition to an elongate web of a fibrous material, wherein the hydrophobic hardenable (co)polymeric ink composition is applied in a plurality of adjacent web regions extending from a first edge of the web to a second edge of the web, wherein each web region is separated from adjacent web regions by a border region; each and wherein each web region includes a hydrophobic area including the hydrophobic (co)polymeric ink composition, a hydrophilic area substantially free of the hydrophobic (co)polymeric ink composition;
- the method further includes providing an optional compressible layer preferably positioned between at least one of the first metallic or (co)polymeric substrate and the porous substrate and/or the second metallic or (co)polymeric substrate and the porous substrate.
- forming the plurality of edge seals around at least a perimeter of the folded web of fibrous material comprises stitching, needle punching, stapling, adhesive bonding, heat-sealing, shrink-wrapping, ultrasonic bonding, or a combination thereof.
- Suitable stitching apparatus and methods are described, for example, in U.S. Pat. No. 5,962,102, the entire disclosure of which is incorporated herein by reference in its entirety.
- Suitable needle punching apparatus and methods are described, for example, in U.S. Pat. No. 9,765,458, the entire disclosure of which is incorporated herein by reference in its entirety.
- Suitable stapling apparatus and methods are described, for example, in U.S. Pat. No. 8,640,704, the entire disclosure of which is incorporated herein by reference in its entirety.
- the plurality of edge seals comprise at least one heat-sealable (co)polymeric film, optionally wherein the plurality of edge seals comprise a first heat-sealable (co)polymeric film and a second heat-sealable (co)polymeric film, wherein a portion of each heat- sealable (co)polymeric film overlays opposed major surfaces of the folded web of fibrous material, further wherein the first and second heat-sealable (co)polymeric films are bonded to each other at a plurality of each heat-sealable (co)polymeric film’s edges which do not overlap the folded web of fibrous material.
- the first and second (co)polymeric substrate heat-sealable (co)polymeric films are independently selected from the group consisting of polyethylene films, polypropylene films, polybutylene films, polycarbonate films and polyester films.
- the methods further include creating at least one access port in the diagnostic device by removing a portion of at least one of the first metallic or (co)polymeric film or the second metallic or (co)polymeric film in a region which overlaps the first hydrophilic region of the porous substrate.
- the elongate porous substrate is chosen from paper, nonwoven materials, (co)polymeric films, and combinations thereof.
- the ink composition is applied to the elongate web of porous substrate by at least one of printing, coating, physical vapor deposition, and combinations thereof.
- the method further includes disposing a reagent in at least one of the hydrophilic areas along the flow path, wherein the reagent is selected to provide an indication of at least one of a presence, an absence, and a concentration of an analyte in the sample.
- a roll-to-roll process is used to produce the diagnostic devices.
- This residual un-solidified liquid ink can then transfer to unpattemed hydrophilic regions of the substrate that passes over the idler at a subsequent time, which can potentially damage later-manufactured devices.
- the total volume of printed ink can be a challenge to cure completely. In this case, it may be necessary to run the porous substrate through multiple UV radiation stations, and it may be difficult to achieve sufficient or complete polymerization of the radiation curable ink. If some of the ink remains unsolidified, the unhardened or partially-solidified ink can contaminate the processing equipment and the hydrophilic regions of the paper - making the diagnostic device ineffective. In some cases, splitting the UV-curing between two- sides of each layer can more fully polymerize the hydrophobic ink composition.
- mechanical fasteners may be used to temporarily maintain the alignment of one or more of the hydrophilic regions in overlying layers or panels of the diagnostic device, either alone or in combination with any of the adhesive layers described above.
- Suitable mechanical fasteners include, but are not limited to, plastic or metal clips, staples, elastic bands such as plastic or rubber bands, plastic zip ties and combinations thereof.
- the mechanical fasteners may also be used to compress the stack of porous substrate layers and maintain intimate contact between layers, which in some examples can reduce wicking times between the layers.
- the hydrophilic regions in the layers should be in intimate contact with each other so that a liquid flows inside paper pores and not in gaps between the layers of the stack.
- intimate contact between the layers of the stack can be enhanced by placing the arms of a clamping mechanical fastener along the edges or folds of the porous substrate.
- Compression can be applied across the whole device or at the folded edges. Compressing the device can provide intimate contact between the layers of the diagnostic device, which can improve the flow of fluid through the layers by avoiding air gaps. In an embodiment, it may be advantageous to only compress the device at the edges. It was found that over-compression of the device decreases the porosity of the hydrophilic regions and inhibits the flow of fluid through the layers.
- Compression of the device can be achieved when the edges of the device are dry or wet. Dry compression can be advantageous when wetting the device is undesirable. Wet compression can be advantageous by decreasing the resistance to bending the fibers at the edge of the device. Wetting of the device can be accomplished by applying a small amount of water along the edges of the device. Compression decreases the spring-like restoring forces of the folded device by bending or breaking the fibers at the edge of the device through high pressure. Additional methods of compressing the device include an arbor press, nipped-roller, other methods known in the art. Methods of Using Encapsulated Paper-based Diagnostic Devices
- a sample solution (not shown in FIGS. 2A-4B) including a sample fluid, solvents, reagents, and the like, is placed on the sample port.
- a wash solution is then applied to the sample port, and the sample solution moves downward via capillary action through the hydrophilic regions of the respective panels of the sensor stack.
- analytes may be detected by direct or indirect detection methods that apply the principles of immunoassays (e.g., a sandwich or competitive immunoassay or ELISA).
- immunoassays e.g., a sandwich or competitive immunoassay or ELISA.
- one or more areas of the hydrophilic regions can be derivatized with reagents, such as antibodies, ligands, receptors, or small molecules that selectively bind to or interact with a protein in the sample fluid.
- reagents such as antibodies, ligands, receptors, or small molecules that selectively bind to or interact with a protein in the sample fluid.
- a test area of the hydrophilic regions can be derivatized with reagents such as antibodies that selectively bind to or interact with that antigen.
- a test area of the hydrophilic regions may be derivatized with antigens that bind or interact with that antibody.
- reagents such as small molecules and/or proteins can be covalently linked to the hydrophilic regions using similar chemistry to that used to immobilize molecules on beads or glass slides, or using chemistry used for linking molecules to carbohydrates.
- the reagents may be applied and/or immobilized in the hydrophilic regions by applying a solution containing the reagent and allowing the solvent to evaporate (e.g., depositing reagent into the hydrophilic region).
- the reagents can be immobilized by physical absorption onto the porous substrate by other non-covalent interactions.
- the interaction of certain analytes with some reagents may not result in a visible color change unless the analyte was previously labeled.
- the devices disclosed herein may be additionally treated to add a stain or a labeled protein, antibody, nucleic acid, or other reagent that binds to the target analyte after it binds to the reagent disposed in the sample flow path 32, which produces a visible color change.
- the device may include a separate area that already contains the stain, or labeled reagent, and includes a mechanism by which the stain or labeled reagent can be easily introduced into the sample flow path to bond to the target analyte after it binds to the reagent.
- the device can be provided with a separate channel that can be used to flow the stain or labeled reagent from a different area of the hydrophilic regions into test area along the sample flow path to the target analyte after it binds to the reagent in the sample flow path. In one embodiment, this flow is initiated with a drop of water, or some other fluid. In another embodiment, the reagent and labeled reagent are applied at the same location in the device, for example, in a test area of one of the hydrophilic regions along the sample flow path.
- ELISA may be used to detect and analyze a wide range of analytes and disease markers with the high specificity, and the result of ELISA can be quantified colorimetrically with the proper selection of enzyme and substrate.
- Detection of an analyte in a sample fluid may include an additional step of creating digital data indicative of an image of a developed test area and the assay result, and transmitting the data remotely for further analysis to obtain diagnostic information, or to store assay results in an appropriate database.
- Some embodiments further include equipment that can be used to image the device after deposition of the liquid to obtain information about the quantity of analyte(s) based on the intensity of a colorimetric response of the device.
- the equipment establishes a communication link with off-site personnel, e.g., via cellular phone communication channels, who perform the analysis based on images obtained by the equipment.
- the entire assay can be completed in less than 30 minutes, 20 minutes, 15 minutes, 10 minutes, or 5 minutes.
- the device can have a detection limit of about 500 pM, 250 pm, 100 pM, 1 pM, 500 fM, 250 fM, or 100 fM.
- the diagnostic device of the present disclosure can be used for assaying small volumes of fluid samples.
- the fluid samples that can be assayed include, but are not limited to, biological samples such as urine, whole blood, blood plasma, blood serum, sputum, cerebrospinal fluid, ascites, tears, sweat, saliva, excrement, gingival cervicular fluid, or tissue extract.
- the volume of fluid sample to be assayed may be a drop of blood, e.g., from a finger prick, or a small sample of urine, e.g., from a newborn or a small animal.
- the sample fluid is an environmental sample such as a water sample obtained from a river, lake, ocean or the like, or a sample of an industrial fluid.
- the device may also be adapted for assaying non-aqueous fluid samples for detecting environmental contamination.
- a single drop of liquid e.g., a drop of blood from a pinpricked finger
- assays providing a simple yes/no answer to determine the presence of an analyte in a sample fluid, or a semi-quantitative measurement of the amount of analyte that is present in the sample, e.g., by performing a visual or digital comparison of the intensity of the assay to a calibrated color chart.
- a defined volume of fluid is typically deposited in the device.
- a defined volume of fluid (or a volume that is sufficiently close to the defined volume to provide a reasonably accurate readout) can be obtained by patterning the hydrophilic substrate to include a sample well that accepts a defined volume of fluid.
- a sample well that accepts a defined volume of fluid.
- the subject's finger could be pinpricked, and then pressed against the sample well until the well was full, thus providing a satisfactory approximation of the defined volume.
- the assay reagents included in the device are selected to provide a visible indication of the presence of one or more analytes in the sample fluid.
- the source or nature of the analytes that may be detected using the disclosed devices are not intended to be limiting.
- Exemplary analytes include, but are not limited to, toxins, organic compounds, proteins, peptides, microorganisms, bacteria, viruses, amino acids, nucleic acids, carbohydrates, hormones, steroids, vitamins, drugs, pollutants, pesticides, and metabolites of or, antibodies to, any of the above substances.
- Analytes may also include any antigenic substances, haptens, antibodies, macromolecules, and combinations thereof. For example, immunoassays using the disclosed devices could be adopted for antigens having known antibodies that specifically bind the antigen.
- the disclosed devices may be used to detect the presence or absence of one or more viral antigens, bacterial antigens, fungal antigens, or parasite antigens, cancer antigens.
- Exemplary viral antigens may include those derived from, for example, the hepatitis A, B, C, or E virus, human immunodeficiency virus (HIV), herpes simplex virus, Ebola virus, varicella zoster virus (virus leading to chicken pox and shingles), avian influenza virus, SARS virus, MERS virus, Epstein Barr virus, rhinoviruses, coronaviruses (such as, for example, the COVID19 coronavirus), and coxsackieviruses.
- HAV human immunodeficiency virus
- herpes simplex virus Ebola virus
- varicella zoster virus virus leading to chicken pox and shingles
- avian influenza virus SARS virus
- MERS virus Epstein Barr virus
- rhinoviruses such as, for example, the COVID19 coronavirus
- coxsackieviruses such as, for example, the COVID19 coronavirus
- Exemplary bacterial antigens may include those derived from, for example, Staphylococcus aureus, Staphylococcus epidermis, Helicobacter pylori, Streptococcus bovis, Streptococcus pyogenes, Streptococcus pneumoniae, Listeria monocytogenes, Mycobacterium tuberculosis, Mycobacterium leprae, Corynebacterium diphtheriae, Borrelia burgdorferi, Bacillus anthracis, Bacillus cereus, Clostridium botulinum, Clostridium difficile, Salmonella typhi, Vibrio chloerae, Haemophilus influenzae, Bordetella pertussis, Yersinia pestis, Neisseria gonorrhoeae, Treponema pallidum, Mycoplasm sp., Legionella pneumophila, Rickettsia typhi, Chlamy
- Exemplary fungal antigens may include those derived from, for example, Tinea pedis, Tinea corporus, Tinea cruris, Tinea unguium, Cladosporium carionii, Coccidioides immitis, Candida sp., Aspergillus fumigatus, and Pneumocystis carinii.
- Exemplary parasite antigens include those derived from, for example, Giardia lamblia, Leishmania sp., Trypanosoma sp., Trichomonas sp., and Plasmodium sp.
- Exemplary cancer antigens may include, for example, antigens expressed, for example, in colon cancer, stomach cancer, pancreatic cancer, lung cancer, ovarian cancer, prostate cancer, breast cancer, liver cancer, brain cancer, skin cancer (e.g., melanoma), leukemia, lymphoma, or myeloma.
- the assay reagents may react with one or more metabolic compounds.
- Exemplary metabolic compounds include, for example, proteins, nucleic acids, polysaccharides, lipids, fatty acids, amino acids, nucleotides, nucleosides, monosaccharides and disaccharides.
- the assay reagent is selected to react to the presence of at least one of glucose, protein, fat, vascular endothelial growth factor, insulin-like growth factor 1, antibodies, and cytokines.
- one or more reagents may be included in any or all of the hydrophilic regions, and one or more of the panels may include a test area to indicate at least one of the presence, the absence, or the concentration of an analyte in a sample fluid.
- each web region may be printed on a separate web or area of a web. After the web is further processed, the individual web regions may then be aligned, placed over each other in a desired order, and stacked to form a suitable diagnostic device. However, in some cases the alignment and stacking steps in such a process may increase the overall manufacturing cost of the diagnostic device compared to the folding process described above.
- example assay methods include adding a fluid sample including an analyte to the hydrophilic regions such that the sample fluid enters and wicks along the sample flow path by capillary action.
- water or a buffer may also be added to the hydrophilic regions to assist in the movement of the sample fluid along the sample flow path.
- the assay protocol produces a color reaction, which includes the development of a grey scale from black to white, and the examination of the development of or, intensity of, the color in the test area within the hydrophilic regions, or within the entire hydrophilic regions, to determine the presence, absence, or concentration of the analyte.
- an ELISA test may be conducted using the disclosed device.
- the method may include the steps of: (1) addition of a sample to the device, wherein the sample is wicked directly through the hydrophilic regions along the sample flow path (2) binding an analyte with a labeled antibody along the flow path and into the test area; and binding the analyte binds to an antigen in the test area; and optionally washing the hydrophilic regions with a buffer such as, for example, PBS, to observe the results in the test area.
- a buffer such as, for example, PBS
- a sample solution (not shown in FIGS. 2A-4B) including a sample fluid, solvents, reagents, and the like, is placed on the sample port.
- the sample solution and fluids may optionally be inserted through the access port in the packaging layer.
- a wash solution is then applied to the sample port, and the sample solution moves downward via capillary action through the hydrophilic regions of the respective panels of the sensor stack.
- Solvents and other reagents used may generally be obtained from Sigma- Aldrich Chemical Company (Milwaukee, WI) unless otherwise noted.
- the first and second (co)polymeric substrates used to encapsulate the porous substrates was a 5 mil thick PET film manufactured by 3M Company (Greenville, NC).
- Other materials are described in co-pending U.S. Prov. Patent Application 63/003,169, filed March 31, 2020 and titled “DIAGNOSTIC DEVICE” and co-pending U.S. Prov. Patent Applications 63/164,144, filed March 22, 2021 and titled “DIAGNOSTIC DEVICE.”
- a diagnostic device or assay device substantially similar to that described schematically in FIG. 4B was prepared that included a thick (about 60 mils or 1.5 mm) cardboard backer card and a clear pressure sensitive adhesive (PSA) tape outer packaging layer fixing the sensor stack to the baker card.
- the outer packaging layer included 2 apertures to provide access to the sensor stack, as well as a pull tab configured to strip away a predetermined portion of the outer packaging layer.
- a compression layer of 90 mil (2.3 mm) closed cell polyethylene (PE) foam was attached to the backer card with an adhesive transfer tape.
- Above the foam layer was a wicking element including 2 sublayers of 0.9 mm wicking pads.
- the bottom sublayer of the wicking layer was attached to the top of the foam layer with an adhesive transfer tape.
- the top sublayer wicking pad has laser-cut lateral flow control features such as shown in FIG. 10A.
- wicking pads were attached to each other with disks of an adhesive transfer tape which also blocked the wicking flow and facilitated the lateral flow control features. Above the top wicking pad the sensor stack was attached to the cover PSA tape with adhesive tape tabs.
- a cover layer above the sensor stack was a 14 mil (0.36 mm) polyethylene terephthalate (PET) sheet.
- PET polyethylene terephthalate
- the cover layer included 2 apertures underlying the apertures in the outer packaging layer, which provided access to the sensor stack from above.
- the backing layer was a PET film that was ultrasonically welded about the periphery of the wicking layer.
- the multilayer sensor stack and the optional compression layer, if present, are compressed before ultrasonically welding or otherwise bonding the backing layer about the periphery of the wicking layer.
- the ultrasonically welding or bonding of the backing layer about the periphery of the wicking layer acts to maintain the multilayer sensor stack in compression even after completion of the ultrasonic welding or bonding of the backing layer about the periphery of the wicking layer.
- the backing layer was 14 mil (0.36 mm) PET
- the outer packaging layer was an injection molded plastic shell.
- the plastic shell included apertures on an upper surface to provide access to the sensor stack.
- Flexographic ink (9418 obtained from NAZDAR Ink Technologies of Shawnee, KANS) was printed on a WHATMAN Grade 1 filter (obtained from GE Healthcare Life Sciences of Piscataway, NJ) paper substrate busing a FLEXIPROOF 100 printing system (obtained from RK Industries, Herts, United Kingdom). Printing was accomplished by using a 38.75 micrometer (25 billions of cubic microns (BCM)), 35.4 lines per centimeter (90 lines per inch) anilox roll to form a 5.08 cm (2 inch) diameter circle.
- BCM cubic microns
- the printed paper sample was heated for eight minutes at 177°C (350°F) and the ink was cured by exposure to UV radiation by a FUSION High Intensity UV curing system (obtained from FUSION UV Systems Inc of Hampshire, United Kingdom) outfitted with an H-bulb and conveyed at 1.5 meters (5 feet) per minute to form a hydrophobic region on the paper sample.
- the printed paper sample was tested for performance by depositing dyed deionized water into non-printed areas and visually inspecting the spread of the dyed water. The dye was added to water to help with observations.
- a test was performed to show that volumetrically hydrophobic areas of the paper retained sufficient fluid permeability. A 5.08 cm (2 inch) diameter round disk was cut out of the printed paper.
- the paper samples were inserted into a standard filter housing and a water line with one meter of head pressure was connected to the filter housing and outflow was measured. Table 3 summarizes these test results.
- a wax-saturated paper was made by melting Batik Wax (available from Jacquard Products, Healdsburg, CA) at 65.6°C (150°F) and dripping it on WHATMAN Grade 1 paper pre-heated to the same temperature until saturation of less than about 5 minutes. A test was performed to show that volumetrically hydrophobic areas of the printed paper retained sufficient fluid permeability. A 5.08 cm (2 inch) diameter round disk was cut out of the printed paper. The paper samples were inserted into a standard filter housing and a water line with one meter of head pressure was connected to the filter housing and outflow was measured. Refer to Table 3 for test results.
- a CH 265 self-adhering adhesive obtained from Valpac Industries, Federalsburg, MD was manually applied by a cotton swab onto the printed regions on both sides of the sample created in Preparatory Example 1. After drying at room temperature for one hour, the sample was folded and lightly pressed together. Dyed water was placed on one side of the sample and wicking to the other side was observed after 25 seconds indicating that fluid transport across layers was successful.
- Flint Group Easy Release Coating (available from Flint Group, Rogers, MN) was flexographically printed on a 12-wide roll of Great Lakes filter paper (equivalent to #1 Whatman, Grade 601, available from Great Lakes Filters, Bloomfield Hills, MI) on custom-made flexographic printing line using 24 bcm (billion cubic microns), 100 lines per inch (about 40 lines per cm) anilox roll at 10 feet per minute (fpm; 5 cm/sec) line speed in a pattern representing an array of 5 folds of bio-diagnostics devices.
- the ink was in-line UV cured on both sides in two passes. Single 5-fold devices were cut out of the roll of paper and folded along unprinted spaces between the prints. 3M spray adhesive (3M Spray Adhesive Super 77®, available from 3M Company, St. Paul, MN) was lightly sprayed by hand on both side of the device over both hydrophobic and hydrophilic areas.
- 3M spray adhesive (3M Spray Adhesive Super 77®, available from 3M Company, St. Paul, MN) was lightly sprayed by hand on both side of the device over both hydrophobic and hydrophilic areas.
- step (1) a hydrophobic ink available from Flint Group under the trade designation Easy Release (UVF03408) UV curable ink was flexographically printed using a 12 BCM/in 2 anilox roll and a patterned LUX ITP60 flexographic printing plate (MacDermid Graphics Solutions, Atlanta, GA) at 20 ft/min (10 cm/sec) onto filter paper onto Great Lakes Filter Paper (Grade: CP51232 - Grade 601) obtained from Ahlstrom-Munksjo Filtration LLC), and the ink was transported to the UV curing station and solidified.
- the time between printing and curing was such that when the paper was transported at 20 ft/min (10 cm/sec), it provided enough time for the ink to wick approximately half the thickness of the filter paper.
- step (2) the printed paper from step (1) was then re-inserted through the printing line at 20 ft/min (10 cm/sec), and a second matching reverse-image pattern of the Flint Group Easy Release ink was printed in registration to the backside (i.e., opposing paper surface to the first pass of printing) of the filter paper.
- the printing was performed with a 12 BCM/in 2 anilox roll and patterned LUX ITP60 flexographic printing plate.
- the printed paper was transported to the UV curing station and solidified at 20 ft/min (10 cm/sec), which was sufficient time for the hydrophobic ink to penetrate the paper and reach the other half-printed hydrophobic barrier layer, completing a barrier layer for a diagnostic device.
- step (2) of this example was tested with red-dyed water to ensure a complete seal was created throughout the thickness of the paper.
- the red-dyed water was deposited into the channels formed by the hydrophobic barriers, dried, and then photo-graphed.
- any of the porous substrates of Preparatory Examples 1-9 may be incorporated into am edge- sealed diagnostic device according to the present disclosure.
- the porous substrate may be positioned between first and second metallic or (co)polymeric substrates (e.g., 5 mil thick PET film manufactured by 3M Company, Greenville, NC) and then a plurality of edge seals may be formed between the first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate.
- first and second metallic or (co)polymeric substrates e.g., 5 mil thick PET film manufactured by 3M Company, Greenville, NC
- the plurality of edge seals around at least a portion of the perimeter of the folded web of fibrous material comprise stitching, needle punching, stapling, adhesive bonding, heat-sealing, shrink- wrapping, ultrasonic bonding, or a combination thereof.
- the plurality of edge seals comprise at least one heat-sealable (co)polymeric film, optionally wherein the plurality of edge seals comprise a first heat-sealable (co)polymeric film and a second heat-sealable (co)polymeric film, wherein a portion of each heat-sealable (co)polymeric film overlays opposed major surfaces of the folded web of fibrous material, further wherein the first and second heat-sealable (co)polymeric films are bonded to each other at a plurality of each heat-sealable (co)polymeric film’s edges which do not overlap the folded web of fibrous material.
- the first and second (co)polymeric substrate heat-sealable (co)polymeric films may be independently selected from the group consisting of polyethylene films, polypropylene films, polybutylene films, polycarbonate films and polyester films.
- an ultrasonic bonding device may be used to bond together the first and second (co)polymeric substrates, thereby fully encapsulating the porous substrate.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Diagnostic devices including a first metallic or (co)polymeric substrate, a second metallic or (co)polymeric substrate opposite the first (co)polymeric substrate and an elongate substantially planar porous substrate positioned between the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, and a multiplicity of edge seals formed between the first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate such that the first and the second metallic or (co)polymeric substrates together substantially surround and encapsulate the porous substrate. An optional compressible layer is preferably positioned between at least one of the first metallic or (co)polymeric substrate and the porous substrate and/or the second metallic or (co)polymeric substrate and the porous substrate. The diagnostic devices are suitable for qualitative or quantitative analysis of a sample fluid. Methods of making the diagnostic devices also are described.
Description
EDGE-SEALED POROUS SUBSTRATE DIAGNOSTIC DEVICESAND METHODS OF
MAKING SAME
TECHNICAL FIELD
[0001] The present disclosure relates to diagnostic devices and more particularly to edge-sealed porous substrate -based (e.g., paper-based) medical and food safety diagnostic devices and methods of making the same.
BACKGROUND
(00021 Simple, low-cost diagnostic technologies are an important component of strategies tor improving healthcare and access to healthcare in de veloping nations and resource-limited settings. According to the World Health Organization, diagnostic devices for use in developing countries should be ASSURED (affordable, sensitive, specific, user-friendly, rapid and robust, equipment-free, and deliverable to end users).
[0003] Inexpensive, portable, and easy-to-use diagnostic devices have used a porous substrate including a reagent selected to rapidly perform quantitative or qualitative analysis of a fluid sample such as, for example, a bodily fluid, an industrial fluid, food samples or water, in the field when laboratory facilities are not available or easily accessed for sample analysis. In one example, a paper- based diagnostic device includes a colorimetric immunoassay reagent with a color change as a readout, and the color change readout can be detected visually or with a machine to provide a rapid, low-cost diagnosis of the presence of an infectious disease.
[0004] In various examples, analytes in a sample can be rapidly detected using the diagnostic devices include viral antigens, bacterial antigens, fungal antigens, parasitic antigens, cancer antigens, metabolic markers, and combinations thereof. In one example, in an immune -chromatographic diagnostic assay, antibodies acting as binding proteins can be used to capture disease-relevant biomarkers from the patient sample, and then produce a visible diagnostic signal resulting from the binding event. 0005| In some examples, the diagnostic devices include multiple layers of a porous material disposed in planes parallel to one another and in face-to-face contact. The various layers of the diagnostic device include fluid impermeable hydrophobic regions and hydrophilic water absorbent regions arranged to provide a sample flow path configured such that a fluid sample can wick or flow from one layer to another. At least some of the layers include reagents, buffer salts, analytes (for example antigens) and binders (for example, antibodies) selected to perform a multiplexed assay.
[0006] U.S, 8,628,729 describes a method for making paper-based devices that includes building fluid- impermeable areas in paper. U.S. 9,669,638 describe ink-jet printing methods for making hydrophobic areas in otherwise hydrophilic media. U.S. 9,597,684 describes other methods for forming liquid- impermeable barriers in hydrophilic media.
SUMMARY
[0007] In general the present disclosure is directed to inexpensive, easy to use
diagnostic devices for quantitative or qualitative analysis of a sample fluid including an analyte. Suitable sample fluids include, but are not limited to, body fluids (e.g., blood, sputum, saliva, or urine), industrial fluids, water samples, and the like. The diagnostic device includes at least two substantially planar portions, each planar portion made from a hydrophilic material such as paper. The planar portions are stacked on each other and each occupy a different and substantially parallel plane to form a three- dimensional porous structure.
[0008] To manufacture a diagnostic device including multiple planar regions of a porous substrate, optionally having different reagents or different patterns of hydrophobic and hydrophilic regions, multiple layers must be individually produced, accurately stacked and aligned to provide the sample flow path, and adhered together in order to maintain the continuity of the sample flow path and form an operable stack. In practice it can be difficult to produce a low-cost diagnostic device using such a complex series of steps, and to date manufacturing costs have limited deployment of these types of diagnostic devices, particularly to resource-limited settings such as developing nations. To provide enhanced diagnostic devices and improve health care, particularly in these developing countries, there remains a need for multiplexed assay devices that are inexpensive, portable, and easy to construct and use.
[0009] When a porous substrate-based (e.g. , paper-based) diagnostic device is made from multiple layers of the porous substrate (e.g. , paper), intimate contact between the porous substrate (e.g., paper) layers is critical for device performance. If a gap is formed between layers of paper, testing fluid will flow laterally in that gap, in addition to normal flow across the layers of paper. When the testing liquid flows laterally in the gaps instead of normal to the layers of paper, it will not react with reagents deposited within the pores of the paper layers. In addition, the time that it takes for liquid to flow a given distance through the layers becomes unpredictable.
[0010] In particular, when a porous substrate-based diagnostic device is formed by folding the porous substrate (e.g., paper), the folds function like springs that push the porous substrate (e.g., paper) layers apart. Methods need to be developed to manage that spring action and ensure that the multilayer porous substrate (e.g., paper) stack is compressed to provide intimate contact between the various layers in the multilayer porous substrate (e.g., paper) stack.
[0011] This disclosure describes multiple methods for maintaining a porous substrate stack (e.g., a paper substrate stack) in a multi-layer porous substrate-based (e.g., paper-based) diagnostic device without significant gaps between the layers of the porous substrate (e.g., paper). The gap between the layers of a multilayer porous substrate stack is considered significant when the thickness of the fully compressed multilayer porous substrate stack is less than 95% of the thickness of the uncompressed multilayer porous substrate stack. For example, an uncompressed multilayer porous substrate stack with ten layers of the porous substrate, where each layer of porous substrate has a porosity of 30% and a thickness of 180 micrometers would theoretically have an uncompressed thickness of 1800 micrometers and a fully
compressed thickness of 1,260 micrometers, corresponding to a 70% air gap or approximately a 60 micrometers-thick air layer for each porous substrate layer in the multilayer porous substrate stack.
[0012] Briefly, in one aspect, the present disclosure describes diagnostic devices including a first metallic or (co)polymeric substrate, a second metallic or (co)polymeric substrate opposite the first (co)polymeric substrate, an elongate substantially planar porous substrate positioned between the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, and a plurality of edge seals formed between the first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate such that the first and the second metallic or (co)polymeric substrates together substantially surround and encapsulate the porous substrate.
[0013] An optional compressible layer is preferably positioned between at least one of the first metallic or (co)polymeric substrate and the porous substrate and/or the second metallic or (co)polymeric substrate and the porous substrate.
[0014] In further optional exemplary embodiments, a first portion of the porous substrate lies in a first plane with respect to the folded region, wherein the first portion of the porous substrate comprises a first hydrophobic region and a first hydrophilic region, wherein the first hydrophobic region comprises a first low surface energy (co)polymeric material extending from a first major surface of the first portion of the porous substrate to a second major surface of the first portion of the porous substrate. The first hydrophobic region includes an arrangement of interconnected open pores providing at least one uninterrupted path extending from the first major surface of the first portion of the porous substrate to the second major surface of the first portion of the porous substrate.
[0015] Preferably, a second portion of the porous substrate lies in a second plane with respect to the folded region, wherein the second plane is substantially parallel to the first plane. The second portion of the porous substrate includes a second hydrophilic region and a second hydrophobic region comprising a second low surface energy (co)polymeric material, which may be the same or different from the first low surface energy (co)polymeric material, extending from a first major surface of the second portion of the porous substrate to second major surface of the second portion of the porous substrate. The second hydrophobic region includes an arrangement of interconnected open pores providing at least one uninterrupted path extending from the first major surface of the second portion of the porous substrate to the second major surface of the second portion of the porous substrate.
[0016] Preferably, at least one connective region is positioned between the first portion of the porous substrate and the second portion of the porous substrate. At least one connective region is configured to maintain alignment of the first hydrophilic region and the second hydrophilic region sufficient to provide a sample flow path between the first portion of the porous substrate and the second portion of the porous substrate along a direction normal to the first plane and the second plane.
[0017] Preferably, a reagent is positioned along the sample flow path. The reagent is selected to detect at least one of a presence, an absence or a concentration of an analyte present in a sample applied to the diagnostic device.
[0018] In another aspect, the present disclosure describes a diagnostic device including a first (co)polymeric substrate, a second (co)polymeric substrate opposite the first (co)polymeric substrate, an elongate substantially planar porous substrate comprising a multiplicity of fibers, and a plurality of edge seals formed between the first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate. The porous substrate is positioned between the first (co)polymeric substrate and the second (co)polymeric substrate such that the first and the second (co)polymeric substrates together substantially surround and encapsulate the porous substrate.
[0019] An optional compressible layer is preferably positioned between at least one of the first metallic or (co)polymeric substrate and the porous substrate and/or the second metallic or (co)polymeric substrate and the porous substrate.
[0020] In further optional exemplary embodiments, the porous substrate includes a multiplicity of folded regions between a first end and a second end of the porous substrate. The multiplicity of folded regions divide the planar porous fibrous substrate into a multilayer stack of overlying substantially planar panels, wherein each of the panels in the multilayer stack occupies a different substantially parallel plane. A connective region is configured to attach adjacent panels to each other.
[0021] Preferably, the planar panels include at least one hydrophobic region including fibers coated with a hydrophobic low surface energy (co)polymeric ink such that open areas remain between the fibers, the open areas between the fibers providing at least one uninterrupted open flow path between a first major surface of the panel and a second major surface of the panel, and at least one hydrophilic region. The hydrophobic regions and hydrophilic regions in adjacent panels of the stack are aligned with each other to provide the sample flow path between the hydrophilic regions thereof along a direction normal to the first plane and the second plane such that the sample contacts the reagent disposed in the flow path to provide an indication of at least one of the presence, absence or concentration of the analyte in the sample.
[0022] Preferably, a reagent is positioned along the sample flow path. The reagent is selected to detect at least one of a presence, an absence or a concentration of an analyte present in a sample applied to the diagnostic device.
[0023] In certain exemplary embodiments of each of the foregoing aspects of the disclosure, the plurality of edge seals comprises at least one cured monomer, oligomer, or (co)polymer, or a combination thereof. In some exemplary embodiments, the plurality of edge seals comprise a first heat-sealable (co)polymeric film and a second heat-sealable (co)polymeric film, wherein a portion of each heat- sealable (co)polymeric film overlays an opposing major surface of the porous substrate, further wherein the first and second heat-sealable (co)polymeric films are bonded to each other at a plurality of each heat- sealable (co)polymeric film’s edges which do not overlap the porous substrate.
[0024] In further exemplary embodiments, the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate further comprise at least one access port created by removing a portion of at least one of the first metallic or (co)polymeric substrate and the second metallic or
(co)polymeric substrate, optionally in a region which overlaps a first hydrophilic region of the porous substrate.
[0025] In additional such exemplary embodiments, the elongate porous substrate is chosen from paper, nonwoven materials, (co)polymeric films, and combinations thereof. It is presently preferred that the elongate porous substrate includes paper.
[0026] The disclosed diagnostic devices are particularly well adapted to conduct immunoassays, such as sandwich or competitive immunoassays, although they may be readily adapted to execute assay formats including steps such as, for example, filtration, multiple incubations with different reagents or combinations of reagents, serial or timed addition of reagents, various incubation times, washing, and the like. The diagnostic devices are particularly effective for executing colorimetric assays, e.g., immunoassays with a color change as a readout, and are easily adapted to execute multiple assays simultaneously. They are extremely sensitive, simple to manufacture, inexpensive, and versatile.
[0027] In a further aspect, the present disclosure is directed to a method of making a diagnostic device, the method including:
[0028] applying a hydrophobic hardenable (co)polymeric ink composition to an elongate web of a fibrous material, wherein the hydrophobic hardenable (co)polymeric ink composition is applied in a plurality of adjacent web regions extending from a first edge of the web to a second edge of the web, wherein each web region is separated from adjacent web regions by a border region; each and wherein each web region includes a hydrophobic area including the hydrophobic (co)polymeric ink composition, a hydrophilic area substantially free of the hydrophobic (co)polymeric ink composition;
[0029] positioning a second metallic or (co)polymeric substrate opposite the (co)polymeric film such that the folded web of fibrous material is positioned between the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate; and
[0030] forming a plurality of edge seals around at least a perimeter of the folded web of fibrous material. [0031] In some exemplary optional embodiments, the method further includes providing an optional compressible layer preferably positioned between at least one of the first metallic or (co)polymeric substrate and the porous substrate and/or the second metallic or (co)polymeric substrate and the porous substrate.
[0032] In certain of the foregoing methods, the plurality of edge seals around at least a perimeter of the folded web of fibrous material comprise stitching, needle punching, stapling, adhesive bonding, heat sealing, shrink-wrapping, ultrasonic bonding, or a combination thereof. In some such embodiments, the plurality of edge seals comprise at least one heat-sealable (co)polymeric film, optionally wherein the plurality of edge seals comprise a first heat-sealable (co)polymeric film and a second heat-sealable (co)polymeric film, wherein a portion of each heat-sealable (co)polymeric film overlays opposed major surfaces of the folded web of fibrous material, further wherein the first and second heat-sealable (co)polymeric films are bonded to each other at a plurality of each heat-sealable (co)polymeric film’s edges which do not overlap the folded web of fibrous material.
[0033] In certain such embodiments, the first and second (co)polymeric substrate heat-sealable (co)polymeric films are independently selected from the group consisting of polyethylene films, polypropylene films, polybutylene films, polycarbonate films and polyester films.
[0034] In some presently preferred embodiments, the method further includes creating at least one access port in the diagnostic device by removing a portion of at least one of the first metallic or (co)polymeric film or the second metallic or (co)polymeric film in a region which overlaps the first hydrophilic region of the porous substrate. In certain presently preferred embodiments, the elongate porous substrate is chosen from paper, nonwoven materials, (co)polymeric films, and combinations thereof. In additional presently preferred embodiments, the ink composition is applied to the elongate web of porous substrate by at least one of printing, coating, physical vapor deposition, and combinations thereof. In other presently preferred embodiments, the method further includes disposing a reagent in at least one of the hydrophilic areas along the flow path, wherein the reagent is selected to provide an indication of at least one of a presence, an absence, and a concentration of an analyte in the sample.
[0035] Various unexpected results and advantages are obtained in exemplary embodiments of the disclosure. One such advantage of exemplary embodiments of the present disclosure is that the reliability and reproducibility of the diagnostic device is improved by providing a controlled, repeatable compressive force to the multilayer paper stack to eliminate air gaps which can adversely affect both the time required to obtain a test result and the dependability and repeatability of the test result. An additional advantage of exemplary embodiments is to provide an adhesive-free assembly method for the diagnostic device, as some adhesives can penetrate into the pores of the multilayer paper stack and inhibit or prevent the wicking of the test sample through the multilayer paper stack in either a vertical or lateral direction.
[0036] Another advantage of exemplary embodiments is to enable a high speed, roll-to-roll continuous production process for the paper substrate and, in certain embodiments, even the paper-based diagnostic device. A further advantage of exemplary embodiments is the ability to achieve a fully automated assembly process for the paper-based diagnostic device. These and other unexpected results and advantages are within the scope of the following exemplary embodiments.
Listing of Exemnlarv Embodiments
Embodiment A: A diagnostic device, comprising: an elongate substantially planar porous substrate with a first end and a second end positioned between a first metallic or (co)polymeric substrate and a second metallic or (co)polymeric substrate such that the first and the second metallic or (co)polymeric substrates substantially surround and encapsulate the porous substrate, wherein the porous substrate comprises at least one folded region between the first end and the second end; a plurality of edge seals formed between the first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate; and
optionally a compressible layer positioned between the first metallic or (co)polymeric substrate and the porous substrate and/or a compressible layer positioned between the second metallic or (co)polymeric substrate and the porous substrate; the diagnostic device optionally further comprising: a first portion of the porous substrate that lies in a first plane with respect to the folded region, wherein the first portion of the porous substrate comprises a first hydrophobic region and a first hydrophilic region, wherein the first hydrophobic region comprises a first low surface energy (co)polymeric material extending from a first major surface of the first portion of the porous substrate to a second major surface of the first portion of the porous substrate, and wherein the first hydrophobic region comprises an arrangement of interconnected open pores providing at least one uninterrupted path extending from the first major surface of the first portion of the porous substrate to the second major surface of the first portion of the porous substrate; and a second portion of the porous substrate that lies in a second plane with respect to the folded region, wherein the second plane is substantially parallel to the first plane, the second portion of the porous substrate comprising a second hydrophilic region and a second hydrophobic region comprising a second low surface energy (co)polymeric material, which may be the same or different from the first low surface energy (co)polymeric material, extending from a first major surface of the second portion of the porous substrate to second major surface of the second portion of the porous substrate, and wherein the second hydrophobic region comprises an arrangement of interconnected open pores providing at least one uninterrupted path extending from the first major surface of the second portion of the porous substrate to the second major surface of the second portion of the porous substrate; at least one connective region between the first portion of the porous substrate and the second portion of the porous substrate, wherein the at least one connective region is configured to maintain alignment of the first hydrophilic region and the second hydrophilic region sufficient to provide a sample flow path between the first portion of the porous substrate and the second portion of the porous substrate along a direction normal to the first plane and the second plane; and a reagent along the sample flow path, wherein the reagent is selected to detect at least one of a presence, an absence or a concentration of an analyte present in a sample applied to the diagnostic device.
Embodiment B: A diagnostic device, comprising: an elongate substantially planar porous substrate comprising a plurality of fibers, wherein a first end and a second end of the porous substrate is positioned between a first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate such that the first and the second (co)polymeric substrates substantially surround and encapsulate the porous substrate, wherein the porous substrate comprises;
a plurality of folded regions between the first end and the second end, the plurality of folded regions dividing the planar porous fibrous substrate into a stack of overlying substantially planar panels, wherein each of the panels in the stack occupies a different substantially parallel plane; a plurality of edge seals formed between the first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate; and optionally a compressible layer positioned between the first metallic or (co)polymeric substrate and the porous substrate and/or a compressible layer positioned between the second metallic or (co)polymeric substrate and the porous substrate, optionally further wherein each of the panels comprises: at least one hydrophobic region comprising the fibers coated with a hydrophobic low surface energy (co)polymeric ink such that open areas remain between the fibers, the open areas between the fibers providing at least one uninterrupted open path between a first major surface of the panel and a second major surface of the panel, and at least one hydrophilic region; and wherein at least some of the panels comprise: a reagent selected to detect an analyte present in a sample, and a connective region configured to attach adjacent panels to each other, wherein the hydrophobic regions and hydrophilic regions in adjacent panels of the stack are aligned with each other to provide a sample flow path between the hydrophilic regions thereof along a direction normal to the first plane and the second plane such that the sample contacts the reagent disposed in the flow path to provide an indication of at least one of the presence, absence or concentration of the analyte in the sample.
Embodiment C: The diagnostic device of Embodiment A or B, wherein the plurality of edge seals comprises at least one cured monomer, oligomer, or (co)polymer, or a combination thereof.
Embodiment D: The diagnostic device of any preceding Embodiment, wherein the plurality of edge seals comprise a first heat-sealable (co)polymeric film and a second heat-sealable (co)polymeric film, wherein a portion of each heat-sealable (co)polymeric film overlays an opposing major surface of the porous substrate, further wherein the first and second heat-sealable (co)polymeric films are bonded to each other at a plurality of each heat-sealable (co)polymeric film’s edges which do not overlap the porous substrate.
Embodiment E: The diagnostic device of any preceding Embodiment, wherein the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate further comprise at least one access port created by removing a portion of at least one of the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, optionally in a region which overlaps the first hydrophilic region of the porous substrate.
Embodiment F : The diagnostic device of any preceding Embodiment, wherein the elongate porous substrate is chosen from paper, nonwoven materials, (co)polymeric films, and combinations thereof.
Embodiment G: The diagnostic device of Embodiment F, wherein the elongate porous substrate comprises paper.
Embodiment H: The diagnostic device of any preceding Embodiment, wherein the optional hydrophobic regions substantially surround the hydrophilic regions.
Embodiment I: The diagnostic device of Embodiments A, C, D, E, G, or H, wherein the optional first and second low surface energy (co)polymeric materials each comprise a radiation curable (co)polymeric ink.
Embodiment J: The diagnostic device of Embodiments A, C, D, E, G, H or I, wherein the optional first and second low surface energy (co)polymeric materials comprise monomers, oligomers, or (co)polymers chosen from fluorocarbons, silicones, or hydrocarbons.
Embodiment K: The diagnostic device of Embodiments A, C, D, E, G, H, I or J, wherein the optional first and second low surface energy (co)polymeric materials comprise a hydrophobic ink with a surface energy lower than 35 dynes/cm.
Embodiment L: The diagnostic device of Embodiments B, C, D, E, G or H, wherein the optional at least one connective region occupies a periphery of the panels and substantially surrounds the optional hydrophobic regions.
Embodiment M: A method of making a diagnostic device, the method comprising: applying a hydrophobic hardenable (co)polymeric ink composition to an elongate web of a fibrous material, wherein the hydrophobic hardenable (co)polymeric ink composition is applied in a plurality of adjacent web regions extending from a first edge of the web to a second edge of the web, wherein each web region is separated from adjacent web regions by a border region; each and wherein each web region comprises: a hydrophobic area comprising the hydrophobic (co)polymeric ink composition, a hydrophilic area substantially free of the hydrophobic (co)polymeric ink composition, and at least partially hardening the hardenable (co)polymeric ink composition in the hydrophobic areas of each web region to provide a hydrophobic ink on fibers of the fibrous material and open areas between the fibers, the open areas between the fibers providing at least one uninterrupted open ink-free flow path between a first major surface of the web and a second major surface of the web; and folding the web of fibrous material along the border regions to form a stack of overlying substantially planar panels, wherein each of the overlying planar panels in the stack occupies a different substantially parallel plane, and wherein each of the overlying planar panels comprises registered hydrophilic areas forming a sample flow path therebetween; positioning a first metallic or (co)polymeric substrate adjacent to the folded web of fibrous material; positioning a second metallic or (co)polymeric substrate opposite the (co)polymeric film such that the folded web of fibrous material is positioned between the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate; and
forming a plurality of edge seals around at least a portion of the perimeter of the folded web of fibrous material, optionally wherein a compressible layer is positioned between the first metallic or (co)polymeric substrate and the folded web of fibrous material and/or the second metallic or (co)polymeric substrate and the folded web of fibrous material.
Embodiment N: The method of Embodiment M, wherein forming the plurality of edge seals around at least a portion of the perimeter of the folded web of fibrous material comprises stitching, needle punching, stapling, adhesive bonding, heat-sealing, shrink-wrapping, ultrasonic bonding, or a combination thereof.
Embodiment O: The method of Embodiment M or N, wherein the plurality of edge seals comprise at least one heat-sealable (co)polymeric film, optionally wherein the plurality of edge seals comprise a first heat-sealable (co)polymeric film and a second heat-sealable (co)polymeric film, wherein a portion of each heat-sealable (co)polymeric film overlays opposed major surfaces of the folded web of fibrous material, further wherein the first and second heat-sealable (co)polymeric films are bonded to each other at a plurality of each heat-sealable (co)polymeric film’s edges which do not overlap the folded web of fibrous material.
Embodiment P: The method of Embodiment M, N or O, wherein the first and second
(co)polymeric substrate heat-sealable (co)polymeric films are independently selected from the group consisting of polyethylene films, polypropylene films, polybutylene films, polycarbonate films and polyester films.
Embodiment Q: The method of Embodiment M, N, O or P, further comprising creating at least one access port in the diagnostic device by removing a portion of at least one of the first metallic or (co)polymeric film or the second metallic or (co)polymeric film in a region which overlaps the first hydrophilic region of the porous substrate.
Embodiment R: The method of Embodiment M, N, O, P or Q, wherein the elongate porous substrate is chosen from paper, nonwoven materials, (co)polymeric films, and combinations thereof. Embodiment S: The method of Embodiment M, N, O, P, Q or R, wherein the ink composition is applied to the elongate web of porous substrate by at least one of printing, coating, physical vapor deposition, and combinations thereof.
Embodiment T: The method of Embodiment M, N, O, P, Q, R or S, further comprising disposing a reagent in at least one of the hydrophilic areas along the flow path, wherein the reagent is selected to provide an indication of at least one of a presence, an absence, and a concentration of an analyte in the sample.
[0037] Various aspects and advantages of exemplary embodiments of the disclosure have been summarized. The above Summary is not intended to describe each illustrated embodiment or every implementation of the present certain exemplary embodiments of the present disclosure. The Drawings and the Detailed Description that follow more particularly exemplify certain preferred embodiments using the principles disclosed herein.
BRIEF DESCRIPTION OF THE DRAWINGS
[0038] The disclosure may be more completely understood in consideration of the following detailed description of various embodiments of the disclosure in connection with the accompanying figures, in which:
[0039] FIG. 1 is a schematic side view of a porous substrate-based (e.g, paper-based) diagnostic device prior to ultrasonic bonding according to an embodiment of the present disclosure.
[0040] FIG. 2A is a schematic top view of a porous substrate-based (e.g. , paper-based) diagnostic device after edge-sealing according to an embodiment of the present disclosure.
[0041] FIG. 2B is a schematic side view of the porous substrate-based (e.g., paper-based) diagnostic device after edge-sealing according to the embodiment shown in FIG. 2A of the present disclosure. [0042] FIG. 3A is a schematic top view of a porous substrate-based (e.g. , paper-based) diagnostic device after edge-sealing according to an alternative embodiment of the present disclosure [0043] FIG. 3B is a schematic side view of a porous substrate-based (e.g., paper-based) diagnostic device after edge-sealing according to the embodiment shown in FIG. 3 A of the present disclosure. [0044] FIG. 4A is a schematic top view of a porous substrate-based (e.g. , paper-based) diagnostic device after edge-sealing according to another alternative embodiment of the present disclosure [0045] FIG. 4B is a schematic side view of a porous substrate-based (e.g., paper-based) diagnostic device after edge-sealing according to the embodiment shown in FIG. 4A of the present disclosure. [0046] In the drawings, like reference numerals indicate like elements. While the above-identified drawings, which may not be drawn to scale, sets forth various embodiments of the present disclosure, other embodiments are also contemplated, as noted in the Detailed Description. In all cases, this disclosure describes the presently disclosed disclosure by way of representation of exemplary embodiments and not by express limitations. It should be understood that numerous other modifications and embodiments can be devised by those skilled in the art, which fall within the scope and spirit of this disclosure.
DETAILED DESCRIPTION
[0047] Certain terms are used throughout the description and the claims that, while for the most part are well known, may require some explanation. For the following Glossary of defined terms, these definitions shall be applied for the entire application, unless a different definition is expressly provided in the claims or elsewhere in the specification.
Glossary
[0048] The terms “(co)polymer” and “(co)polymer” include homopolymers and copolymers, such as homopolymers or copolymers that may be formed in a miscible blend, e.g., by coextrusion or by reaction, including, e.g., transesterification. The term “copolymer” includes both random and block copolymers. [0049] The term “coupling agent” means a compound which provides a chemical bond between two dissimilar materials, usually an inorganic and an organic material. Coupling agents are typically multi -
functional molecules or oligomers which can act to effect crosslinking during chemical reactions, for example, a chemical reaction such as free radical polymerization to form a (co)polymer.
[0050] The term “layer” refers to a single stratum within a multi-strata (multilayer) assembly.
[0051] The term “encapsulate” or “encapsulated” means enclosed or encased within.
[0052] The term "(meth)acryl" or “(meth)acrylate” with respect to a monomer, oligomer, (co)polymer or compound means a vinyl-functional alkyl ester formed as the reaction product of an alcohol with an acrylic or a methacrylic acid.
[0053] The term "crosslinked" (co)polymer refers to a (co)polymer whose (co)polymer chains are joined together by covalent chemical bonds, usually via crosslinking molecules or groups, to form a network (co)polymer. A crosslinked (co)polymer is generally characterized by insolubility but may be swellable in the presence of an appropriate solvent.
[0054] The term “cure” refers to a process that causes a chemical change, e.g., a reaction that creates a covalent bond to solidify a multilayer film layer or increase its viscosity.
[0055] The term "cured (co)polymer" includes both crosslinked and uncrosslinked polymers.
[0056] By using the term "Tg", we refer to the glass transition temperature of a (co)polymer when evaluated in bulk rather than in a thin film form. In instances where a (co)polymer can only be examined in thin film form, the bulk form Tg can usually be estimated with reasonable accuracy. Bulk form Tg values usually are determined by evaluating the rate of heat flow vs. temperature using differential scanning calorimetry (DSC) to determine the onset of segmental mobility for the (co)polymer and the inflection point (usually a second-order transition) at which the (co)polymer can be said to change from a glassy to a rubbery state. Bulk form Tg values can also be estimated using a dynamic mechanical thermal analysis (DMTA) technique, which measures the change in modulus of the (co)polymer as a function of temperature and frequency of vibration of a test sample.
[0057] The term “adjoining” with reference to a particular layer means joined with or attached to another layer, in a position wherein the two layers are either next to (i.e.. adjacent to) and directly contacting each other, or contiguous with each other but not in direct contact (i.e.. there are one or more additional layers intervening between the layers).
[0058] By using terms of orientation such as “atop”, “on”, “over,” “covering”, “uppermost”, “underlying” and the like for the location of various elements in the disclosed coated articles, we refer to the relative position of an element with respect to a horizontally-disposed, upwardly-facing substrate. However, unless otherwise indicated, it is not intended that the substrate or articles should have any particular orientation in space during or after manufacture.
[0059] By using the term “overcoated” to describe the position of a layer with respect to a substrate or other element of an article of the present disclosure, we refer to the layer as being atop the substrate or other element, but not necessarily contiguous to either the substrate or the other element.
[0060] By using the term “separated by” to describe the position of a layer with respect to other layers, we refer to the layer as being positioned between two other layers but not necessarily contiguous to or adjacent to either layer.
[0061] The terms “about” or “approximately” with reference to a numerical value or a shape means +/- five percent of the numerical value or property or characteristic, but expressly includes the exact numerical value. For example, a viscosity of “about” 1 Pa-sec refers to a viscosity from 0.95 to 1.05 Pa- sec, but also expressly includes a viscosity of exactly 1 Pa-sec. Similarly, a perimeter that is “approximately square” is intended to describe a geometric shape having four lateral edges in which each lateral edge has a length which is from 99% to 101% of the length of any other lateral edge, but which also includes a geometric shape in which each lateral edge has exactly the same length.
[0062] Unless otherwise indicated, all numbers expressing quantities or ingredients, measurement of properties and so forth used in the specification and embodiments are to be understood as being modified in all instances by the term “about.” Accordingly, unless indicated to the contrary, the numerical parameters set forth in the foregoing specification and attached listing of embodiments can vary depending upon the desired properties sought to be obtained by those skilled in the art utilizing the teachings of the present disclosure. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the claimed embodiments, each numerical parameter should at least be construed in light of the number of reported significant digits and by applying ordinary rounding techniques.
[0063] The term “substantially” with reference to a property or characteristic means that the property or characteristic is exhibited to a greater extent than the opposite of that property or characteristic is exhibited. For example, a substrate that is “substantially” transparent refers to a substrate that transmits more radiation (e.g. visible light) than it fails to transmit (e.g. absorbs and reflects). Thus, a substrate that transmits more than 50% of the visible light incident upon its surface is substantially transparent, but a substrate that transmits 50% or less of the visible light incident upon its surface is not substantially transparent.
[0064] As used in this specification and the appended embodiments, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. Thus, for example, reference to fine fibers containing “a compound” includes a mixture of two or more compounds. As used in this specification and the appended embodiments, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
[0065] As used in this specification, the recitation of numerical ranges by endpoints includes all numbers subsumed within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.8, 4, and 5).
[0066] By definition the total weight percentages of all ingredients in a composition equals 100 weight percent.
[0067] Various exemplary embodiments of the disclosure will now be described. Exemplary embodiments of the present disclosure may take on various modifications and alterations without
departing from the spirit and scope of the present disclosure. Accordingly, it is to be understood that the embodiments of the present disclosure are not to be limited to the following described exemplary embodiments but is to be controlled by the limitations set forth in the claims and any equivalents thereof.
Edge-sealed Paper-based Diagnostic Devices
[0068] In one exemplary embodiment, the present disclosure describes diagnostic devices including a first metallic or (co)polymeric substrate, a second metallic or (co)polymeric substrate opposite the first (co)polymeric substrate, an elongate substantially planar porous substrate positioned between the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, and a plurality of edge seals formed between the first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate such that the first and the second metallic or (co)polymeric substrates together substantially surround and encapsulate the porous substrate.
[0069] In other exemplary embodiments, the present disclosure describes a diagnostic device including a first (co)polymeric substrate, a second (co)polymeric substrate opposite the first (co)polymeric substrate, an elongate substantially planar porous substrate comprising a multiplicity of fibers positioned between the first (co)polymeric substrate and the second (co)polymeric substrate, and a plurality of edge seals formed between the first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate such that the first and the second metallic or (co)polymeric substrates together substantially surround and encapsulate the porous substrate.
[0070] In any of the foregoing embodiments, an optional compressible layer is preferably positioned between at least one of the first metallic or (co)polymeric substrate and the porous substrate and/or the second metallic or (co)polymeric substrate and the porous substrate.
[0071] In practice, when a diagnostics device is made from multiple layers (e.g., paper), intimate contact between layers is important for reproducible device performance. When an air gap is formed between adjacent or adjoining layers of the porous substrate such as paper, the testing fluid may flow in that gap, in addition to flowing within the porous structure of the porous substrate. When liquid flows in the gaps instead of within a porous layer of the porous substrate, it may not react with reagents deposited in that layer. In addition, liquid flow in the device may become unpredictable or non-reproducible.
[0072] Thus, in some embodiments, the optional first compressible layer may be advantageously applied to compress the stacked layers tightly against each other to eliminate or mitigate a significant gap between the adjacent porous substrate layers or portions thereof. In some cases, a gap is considered significant when the gap is greater than 75 micrometers, greater than 50 micrometers, greater than 25 micrometers, greater than 10 micrometers, greater than 5 micrometers, greater than 2 micrometers, greater than one micrometer and the like. In some cases, a gap is considered significant when the fraction of fluid sample flowing into the gap is more than 20 weight %, more than 10 weight %, 5 weight %, 2 weight %, 1 weight % and the like.
[0073] Suitable metallic or (co)polymeric substrates, porous substrates, optional compressible layers and diagnostic devices are described in co-pending U.S. Prov. Patent Application 63/003,169, fded March 31, 2020 and titled “DIAGNOSTIC DEVICE”; co-pending U.S. Prov. Patent Application 63/164,144, fded March 22, 2021 and titled “DIAGNOSTIC DEVICE”; co-pending U.S. Prov. Patent Application 63/200,871, fded March 31, 2021 and titled “UUTRASONICAUUY -BONDED POROUS SUBSTRATE DIAGNOSTIC DEVICES AND METHODS OF MAKING SAME”; co-pending U.S. Prov. Patent Application 63/200,844, fded March 31, 2021 and titled “ENCAPSULATED POROUS SUBSTRATE DIAGNOSTIC DEVICES AND METHODS OF MAKING SAME”; co-pending U.S. Prov. Patent Application 63/200,849, fded March 31, 2021 and titled “EDGE-SEALED POROUS SUBSTRATE DIAGNOSTIC DEVICES AND METHODS OF MAKING SAME”; co-pending U.S. Prov. Patent Application 63/200,869, fded March 31, 2021 and titled “CURVED DIAGNOSTIC DEVICE”; as well as any patent applications claiming priority to these provisional patent applications, the entire disclosures of which are incorporated herein by reference in their entireties.
[0074] In certain exemplary embodiments of any of the foregoing diagnostic devices of the present disclosure, the plurality of edge seals comprises at least one cured monomer, oligomer, or (co)polymer, or a combination thereof. In some exemplary embodiments, the plurality of edge seals comprise a first heat-sealable (co)polymeric film and a second heat-sealable (co)polymeric film, wherein a portion of each heat-sealable (co)polymeric film overlays an opposing major surface of the porous substrate, further wherein the first and second heat-sealable (co)polymeric films are bonded to each other at a plurality of each heat-sealable (co)polymeric film’s edges which do not overlap the porous substrate.
[0075] In further exemplary embodiments, the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate further comprise at least one access port created by removing a portion of at least one of the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, optionally in a region which overlaps a first hydrophilic region of the porous substrate.
[0076] In additional such exemplary embodiments, the elongate porous substrate is chosen from paper, nonwoven materials, (co)polymeric films, and combinations thereof. It is presently preferred that the elongate porous substrate includes paper.
[0077] The disclosed diagnostic devices are particularly well adapted to conduct immunoassays, such as sandwich or competitive immunoassays, although they may be readily adapted to execute assay formats including steps such as, for example, filtration, multiple incubations with different .or combinations of reagents, serial or timed addition of reagents, various incubation times, washing, and the like. The diagnostic devices are particularly effective for executing colorimetric assays, e.g., immunoassays with a color change as a readout, and are easily adapted to execute multiple assays simultaneously. They are extremely sensitive, simple to manufacture, inexpensive, and versatile.
[0078] Turning now to FIG. 1, a porous substrate -based (e.g., paper-based) diagnostic device 100 according to an embodiment of the present disclosure is shown prior to compression and edge-sealing.
The device 100 comprises a porous substrate 102, which may be a paper web, having a plurality of substantially planar opposed faces 102 (a-e) and a plurality of edges 104 for folding the porous substrate 102 upon itself to form a multilayer porous substrate (e.g., paper) stack.
[0079] FIG. 2A is a schematic top view of a porous substrate-based (e.g. , paper-based) diagnostic device 200 after edge-sealing according to an embodiment of the present disclosure. FIG. 2B is a schematic side view of the porous substrate-based (e.g., paper-based) diagnostic device 200 of FIG. 2A after edge sealing.
[0080] A porous substrate (e.g., paper) 202 is shown folded upon itself at a plurality of edges 204 to form a multilayer porous substrate (e.g, paper) stack. A plurality of edge seals 208 is formed between first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate.
[0081] The plurality of edge seals 208 may be formed by adhesive bonding as shown in FIG. 2A, or by stitching, needle punching, stapling, heat-sealing, shrink-wrapping, ultrasonic bonding, or a combination thereof.
[0082] Referring again to FIG. 2A, a first access port 206a optionally may be created by removing a portion of at least one of the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, optionally in a region which overlaps a first hydrophilic region of the porous substrate. A second access port 206b optionally may be created by removing a portion of at least one of the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, optionally in a region which overlaps a first hydrophilic region of the porous substrate.
[0083] For a lateral flow diagnostic device, the second access port 206b is preferably positioned on the same side of the porous substrate 202 as the first access port 206a as shown in FIG. 2A. For a vertical flow diagnostic device, the second access port 206b is preferably positioned on the opposite side of the porous substrate 202 as the first access port 206a.
[0084] FIG. 3A is a schematic top view of a porous substrate-based (e.g. , paper-based) diagnostic device 300 after edge-sealing according to an alternative embodiment of the present disclosure. FIG. 3B is a schematic side view of the porous substrate-based (e.g., paper-based) diagnostic device 300 of FIG. 3A after edge-sealing according to an alternative embodiment of the present disclosure.
[0085] A porous substrate (e.g., paper) 302 is shown folded upon itself at a plurality of edges 304 to form a multilayer porous substrate (e.g, paper) stack. A plurality of edge seals 308 is formed between first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate.
[0086] The plurality of edge seals 308 may be formed by stitching as shown in FIG. 3 A, or by needle punching, stapling, adhesive bonding, heat-sealing, shrink-wrapping, ultrasonic bonding, or a combination thereof.
[0087] Referring again to FIG. 3A, a first access port 306a optionally may be created by removing a portion of at least one of the first metallic or (co)polymeric substrate and the second metallic or
(co)polymeric substrate, optionally in a region which overlaps a first hydrophilic region of the porous substrate. A second access port 306b optionally may be created by removing a portion of at least one of the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, optionally in a region which overlaps a first hydrophilic region of the porous substrate.
[0088] For a lateral flow diagnostic device, the second access port 306b is preferably positioned on the same side of the porous substrate 302 as the first access port 306a as shown in FIG. 3A. For a vertical flow diagnostic device, the second access port 306b is preferably positioned on the opposite side of the porous substrate 302 as the first access port 306a.
[0089] FIG. 4A is a schematic top view of a porous substrate-based (e.g. , paper-based) diagnostic device 400 after edge-sealing according to another alternative embodiment of the present disclosure. FIG. 4B is a schematic side view of the porous substrate-based (e.g., paper-based) diagnostic device 400 of FIG. 4A after edge sealing according to another alternative embodiment of the present disclosure.
[0090] A porous substrate (e.g., paper) 402 is shown folded upon itself at a plurality of edges 404 to form a multilayer porous substrate (e.g., paper) stack. A plurality of edge seals 408 is formed between first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate.
[0091] The plurality of edge seals 408 may be formed by stapling as shown in FIG. 4A, or by stitching, needle punching, adhesive bonding, heat-sealing, shrink-wrapping, ultrasonic bonding, or a combination thereof.
[0092] Referring again to FIG. 4A, a first access port 406a optionally may be created by removing a portion of at least one of the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, optionally in a region which overlaps a first hydrophilic region of the porous substrate. A second access port 406b optionally may be created by removing a portion of at least one of the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate, optionally in a region which overlaps a first hydrophilic region of the porous substrate.
[0093] For a lateral flow diagnostic device, the second access port 406b is preferably positioned on the same side of the porous substrate 402 as the first access port 406a as shown in FIG. 4A. For a vertical flow diagnostic device, the second access port 406b is preferably positioned on the opposite side of the porous substrate 402 as the first access port 406a.
[0094] In some exemplary embodiments, the diagnostic device includes an elongate substantially planar hydrophilic porous substrate with a first (terminal) end, a second, opposed (terminal) end and at least one folded region between the first and the second ends. The folded region separates the hydrophilic substrate into a first sheet-like portion and a second sheet-like portion, each occupying a substantially parallel plane with respect to the folded region.
[0095] The first porous substrate portion includes a first major surface and a second opposed major surface, while the second substrate portion includes a first major surface and a second opposed major
surface. In the embodiment of FIGs. 2A-4B, the first portion of the substrate and the second portion of the substrate overlie one another such that the respective major surfaces are adjacent to each other.
[0096] The first substrate portion includes a first hydrophobic region and a first hydrophilic region, while the second substrate portion includes a second hydrophobic region and a second hydrophilic region. The fibers of the substrate in the hydrophobic regions have applied thereto a low surface energy polymeric material, and as such resist unassisted capillary fluid flow or wicking of a selected fluid, such as, for example, a sample fluid including, for example, an analyte, or a buffer or a wash solution, therethrough. As a result of this resistance, the selected fluid is passively transported (requiring no external pressure gradients, gravitational or electrostatic forces) between the hydrophilic regions.
[0097] The hydrophobic regions substantially confine the flow of the fluid to a direction normal to the planar surface of the folded paper stack and which is aligned along the thickness of the substrate portions or along the z-axis of the three-dimensional diagnostic device normal to the major surfaces of the porous substrate. The hydrophilic regions are sufficiently aligned with each other such that a fluid sample placed on the first hydrophilic region (not shown in FIGs. 2A-4B) can be passively transported using, for example, wicking or capillary action, along a sample flow path to provide fluid communication between the first substrate portion and the second substrate portion such that the fluid sample wicks into the second hydrophilic region.
[0098] The shapes and sizes of the hydrophobic regions and the hydrophilic regions may vary widely depending on the intended use of the device. Any number of hydrophobic regions and hydrophilic regions may be used. However, since mass transfer of a fluid is proportional to the area of the wicking, varying the size of the hydrophilic regions or a coating pattern of the hydrophobic regions can be used to control mass transfer by wicking or capillary action across layers. For example, smaller hydrophilic regions will reduce mass transfer in direct relation to the reduced area of the substrate occupied by the hydrophilic regions. In some embodiments, which are provided by way of example and are not intended to be limiting, to provide good wicking between overlying layers the hydrophilic regions should occupy about 10% to about 90%, or about 25% to about 50%, of the total cross-sectional area of the substrate. [0099] In some embodiments, the separation regions are free of the hydrophobic regions, but such an arrangement is not required. The hydrophobic regions and the hydrophilic regions may have the same shape, but in some embodiments the hydrophobic regions and hydrophilic regions can have different shapes, depending on the requirements of a specific diagnostic assay.
[00100] In the embodiments of FIGs. 2A-4B, the web regions further include connective regions that surround the hydrophilic regions. In addition, in the embodiment of FIG. 2A, the web region includes a patterned connective region of, for example, a pressure sensitive adhesive (PSA).
[00101] As shown in FIGs. 1, the web may be folded along the separation regions to form a folded paper diagnostic device including overlying and substantially parallel panels. When so folded, the connection regions come together to adhere and maintain registration of the panels, and the patterned connective region maintains the registration of the panels. The registration of the panels maintains alignment of the
hydrophilic regions, which allows flow of sample fluid along a sample flow path through the hydrophilic regions.
[00102] While not shown in FIG.1, additional connective regions of any suitable shape or configuration may be used to temporarily maintain alignment of the hydrophilic regions in the panels. In some embodiments, mechanical fasteners (not shown in FIGS. 2A-4B) may also be used, alone or in combination with adhesive connective regions, to temporarily maintain alignment of any or all of the panels.
[00103] In another embodiment a diagnostic device includes a sensor stack formed from a plurality of overlying substantially planar panels of a porous material. Each of the panels of the sensor stack include a hydrophobic region and a hydrophilic region. The hydrophilic regions are substantially aligned with each other to provide a sample flow path along the direction substantially normal to a first major surface to a second major surface thereof.
[00104] The hydrophilic region provides an exposed sample port upon which a sample fluid is placed for analysis in the sensor stack, and as discussed in detail above the sample fluid moves through the panels by wicking or capillary action. An optional wicking layer includes a first major surface on the second major surface of the sensor stack, as well as a second major surface.
[00105] In some embodiments, the sample port formed by the hydrophilic region may optionally be colored to enhance contrast with the surrounding hydrophobic region and provide a guide for sample placement on the sensor stack. In some embodiments, the hydrophilic region may also be colored to provide a color zone for reading the results of an assay performed with the sensor stack.
[00106] The sensor stack is preferably overlain by a packaging layer. The packaging layer may vary widely, and can include, for example, a (co)polymeric film, a plastic molded cover, and the like. In some embodiments, the packaging layer is an elastic polymeric film that contacts the first major surface of the sensor stack and compresses the sensor stack against the first major surface of the wicking layer. In some examples, such compression can improve wicking through the panels in the sensor stack.
[00107] In other embodiments, the packaging layer comprises at least on thermoplastic (co)polymeric film that contacts the first major surface of the sensor stack and compresses the sensor stack against the first major surface of the wicking layer. Preferably, the thermoplastic (co)polymeric film is a heat- sealable film.
[00108] In some examples, the packing layer may optionally include an access port aligned with the hydrophilic region of the sensor stack. The packaging layer may be attached to the first major surface of the wicking layer by a hinge.
[00109] In another exemplary embodiment, a diagnostic device includes a sensor stack formed from a plurality of overlying substantially planar panels of a porous material such as, for example, paper. As discussed above, the panels may be discrete pieces of the porous material or may be a continuous web of porous material that is folded to form the individual panels. Each of the panels of the sensor stack may preferably include a hydrophobic region and a hydrophilic region. The hydrophilic regions are
substantially aligned with each other to provide a sample flow path through the thickness of the sensor stack from a first major surface to a second major surface thereof.
[00110] The hydrophilic region preferably provides an exposed sample port upon which a sample fluid is placed for analysis in the sensor stack, and as discussed in detail above the sample fluid moves through the panels in direction substantially normal to the first and second major surfaces by wicking or capillary action.
[00111] An optional wicking layer includes a first major surface on the second major surface of the sensor stack, as well as an exposed second major surface. The optional wicking layer, which in various embodiments is made of paper, woven materials, non-woven materials, glass fibers, and the like, helps to draw the sample fluid through the hydrophilic regions in the respective panels to increase the speed and efficiency of the capillary action process.
[00112] In some embodiments, the sample port formed by the hydrophilic region may optionally be colored to enhance contrast with the surrounding hydrophobic region and provide a guide for sample placement on the sensor stack. In some embodiments, the hydrophilic region may also be colored to provide a color zone for reading for reading the results of an assay performed with the sensor stack. [00113] Another exemplary embodiment of an assay device includes a sensor stack formed from multiple overlying planar panels of a porous material. In some embodiments, the sensor stack is formed from a single piece of porous material that is folded into multiple overlying planar panels. The sensor stack includes a first major surface and a second major surface. The panels of the sensor stack preferably include hydrophobic regions and hydrophilic regions, wherein the hydrophilic regions in each panel overlie and are aligned with each other to provide a sample flow path for migration of a fluid sample through the sensor stack from one panel to another along a direction substantially normal to the first an second major surfaces.
[00114] As discussed in the embodiments described above, the assay device may further include an optional wicking layer with a first major surface adjacent to the second major surface of the sensor stack, as well as an opposed second major surface. As noted above, the wicking layer may be a single layer, or may include multiple sublayers.
[00115] In some embodiments, the sublayers of the wicking layer may optionally additionally be bonded together with adhesives, and in some examples the adhesives may be positioned to further enhance flow between the hydrophilic regions of the sensor stack, or to enhance the performance of lateral flow control features in the sublayers.
[00116] In some embodiments, the assay device further includes an outer packaging layer that overlies the cover layer, if present, or the first major surface of the sensor stack. In some embodiments, the outer packaging layer is a polymeric tape construction with an adhesive layer that adheres to a surface of the backing layer.
[00117] In some presently preferred embodiments, the outer packaging layer is an adhesive-free (co)polymeric film that is heat-sealed or ultrasonically welded to the surface of the backing layer. In
some example, the outer packaging layer includes an “easy open” feature such as a tab or a strippable portion that can provide access to the hydrophilic regions of the sensor stack.
[00118] In some embodiments, the polymeric film of the outer packaging layer has elastic properties and exerts a compressive force on the sensor stack in a direction substantially normal to the first and second major surfaces of the porous stack to facilitate the optimal fluid transport rate and avoid lateral capillary flow between the stacked or folded panels thereof. In some embodiments, the outer packaging layer includes apertures (not shown in FIG. 2A-4B) that overlie the apertures in the cover layer and the hydrophilic regions of the sensor stack. The overlying apertures in the cover layer and the outer packaging layer allow application of a sample fluid through the packaging layer and the cover layer onto the hydrophilic regions of the sensor stack.
[00119] In some embodiments, one or more optional adhesive layers, which may be single-sided or double-sided, may optionally be used to bond the wicking layer and the compression layer, or to bond the compression layer to the backing layer, or both. In some examples, an optional arrangement of adhesive tabs on the second major surface of the sensor stack may be used to securely bond the sensor stack to the outer packaging layer. In some examples, some or all of the adhesive layers or the adhesive tabs may be replaced with ultrasonic welds.
[00120] In various embodiments, the elongate hydrophilic substrate may be made from any porous, hydrophilic, adsorbent material capable of wicking a sample fluid by capillary action. In one or more embodiments, the substrate is a paper product such as, for example, chromatographic paper, filter paper, and the like, but may also be chosen from woven or nonwoven fabrics, or from (co)polymer films such as, for example, nitrocellulose, cellulose acetate, polyesters, and polyurethane, and the like.
[00121] The first and second hydrophobic regions may be formed by applying a desired pattern of a low surface energy polymeric material such as, for example, a polymeric ink composition that forms a low surface energy polymeric ink when cured, to the substrate.
[00122] The hydrophobic regions thus resist absorption of a liquid applied to, for example, the hydrophilic region of the first substrate portion, and the liquid is passively transported via capillary action or wicking between the hydrophilic regions. While not wishing to be bound by any theory, currently available evidence indicates that the relative difference in absorption between the hydrophobic regions and the hydrophilic regions is a function of difference between the surface energy of the fibers in the hydrophilic regions for a selected liquid such as, for example, a sample fluid, a buffer, and the like, which are intended to flow between the substrate portions, and the surface energy of the fibers coated with an ink composition deposited or patterned onto the substrate and subsequently cured to form the low surface energy ink in the hydrophobic regions. The larger this difference, the larger the resistivity to absorption of the selected fluid in the hydrophobic regions. The difference may also depend on, for example, the uniformity of ink coverage, the structure of the fibers, and the like.
[00123] In one example, if the sample fluid selected to flow by wicking or capillary action between the substrate portions is a bodily fluid, the surface energy of the fibers with the low surface energy
hydrophobic ink applied thereto in the hydrophobic regions should be lower than the lowest value of the surface tension of the bodily fluid. Because bodily fluids have a range of surface tensions, the surface energy of the fibers in the hydrophobic regions should be at least 10 dynes/cm lower than the lowest surface tension of the bodily fluid, or at least 15 dynes/cm lower, or at least 20 dynes/cm lower, or even at least 30 dynes/cm lower.
[00124] For example, it is reported that human urine has a minimum surface tension of about 55 dynes/cm, and human saliva has a surface tension of about 40 dynes/cm, so to resist absorption of these bodily fluids by wicking or capillary action the hydrophobic regions 24, 28 surface energy of ink should have a surface tension of less than about 45 dynes/cm, or less than about 40 dynes/cm, or less than about 35 dynes/cm, or less than about 30 dynes/cm, or less than about 25 dynes/cm, or less than about 20 dynes/cm.
[00125] In another example, to resist capillary flow or wicking of a selected fluid, presently available evidence indicates that the hydrophobic ink compositions in the regions, when hardened, provide a contact angle for the selected fluid of greater than about 90°, or greater than about 95°, or greater than about 100°, or greater than about 105°, or greater than about 110°, or greater than about 115°, or greater than about 120°, or greater than about 125°, or greater than about 130°, or greater than about 135°, or even greater than about 140°.
[00126] Contact angles and wettability may be measured using the techniques described in, for example, CAPILLARITY AND WETTING PHENOMENA DROPS, BUBBLES, PEARLS, WAVES by Francoise Brochard-Wyart; David Quere, Hardcover; New York: Springer, September 12, 2003; WETTABILITY (SURFACTANT SCIENCE) by John Berg, ed., CRC Press; 1 edition, April 20, 1993, each of which are incorporated herein by reference in their entirety.
[00127] In various embodiments, the hydrophobic ink composition includes at least one polymerizable low surface energy monomer, oligomer, or (co)polymer that can provide a desired resistance to absorption of a selected liquid or sample fluid. This low surface energy monomer, oligomer, or (co)polymer can be a fluorocarbon, silicone, or hydrocarbon. The low surface energy monomer, oligomer, or (co)polymer is added to the formulation to reduce the surface energy of the cured hydrophobic coating to a wetting tension of from about 30 to less than about 38 mJ/m2 as measured by ASTM D 2578-08. Examples of suitable polymerizable low surface energy monomers, oligomers and polymers are described in WO2011/094342, which is incorporated by reference herein in its entirety. [00128] In general, a wide variety of reagents may be disposed in, or in fluid communication with, the test area in hydrophilic regions of the diagnostic device to detect one or more analytes in a sample fluid. These reagents include, but are not limited to, antibodies, nucleic acids, aptamers, molecularly-imprinted polymers, chemical receptors, proteins, peptides, inorganic compounds, and organic small molecules. In a given device, one or more reagents may be adsorbed to one or more hydrophilic regions (non- covalently through non-specific interactions), or covalently (as esters, amides, imines, ethers, or through carbon-carbon, carbon-nitrogen, carbon-oxygen, or oxygen-nitrogen bonds).
[00129] Any reagent needed in the assay may be provided within, or in a separate adsorbent layer in fluid communication with the test area within the hydrophilic regions and the sample flow path. Exemplary assay reagents include protein assay reagents, immunoassay reagents (e.g., ELISA reagents), glucose assay reagents, sodium acetoacetate assay reagents, sodium nitrite assay reagents, or a combination thereof. In various embodiments, which are not intended to be limiting, the diagnostic device may include, a blocking agent, enzyme substrate, specific binding reagent such as an antibody or sFv reagent, labeled binding agent, e.g., labeled antibody, may be disposed in the device within or in flow communication with one or more of the hydrophilic regions, or in a specific area thereof configured as a test area.
[00130] In some embodiments, a binder, e.g., an antibody, may be labeled with an enzyme or a colored particle to permit colorimetric assessment of analyte presence or concentration in a sample fluid. For example, the binder may be labeled with gold colloidal particles or the like as the color forming labeling substance. Where an enzyme is involved as a label, e.g., alkaline phosphatase, horseradish peroxidase, luciferase, or b-galactosidase, an enzyme substrate may be disposed in the device within or in flow communication with one of the hydrophilic regions.
[00131] Exemplary substrates for these enzymes include BCIP/NBT, 3,3',5,5'-Tetramethylbenzidine (TMB), 3,3'-Diaminobenzidine (DAB), and 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS), 4-methylumbelliferphosphoric acid, 3-(4-hydroxyphenyl)-propionic acid, or 4- methylumbellifer- -D-galactoside, or the like.
[00132] In various embodiments, the reagent(s) develop color in one or more test areas along the sample path (including gradations from white to black) as an indication of the presence, absence or concentration of an analyte in a sample.
[00133] In some embodiments, a device may include many reagents disposed along the sample flow path, each of which can react with a different analyte to produce a detectable effect. Alternatively, the reagents may be sensitive to a predetermined concentration of a single analyte.
[00134] In some embodiments, the reagent may include a washing reagent, or plural wash reagents such as buffers or surfactant solutions, within or in fluid communication with a hydrophilic region or the sample flow path. Washing reagent(s) function to wash an analyte by removing unbound species within the hydrophilic regions. For example, a suitable washing buffer may comprise phosphate buffered saline (PBS), detergent, surfactants, water, and salt. The composition of the washing reagent will vary in accordance with the requirements of the specific assay such as, for example, the particular capture reagent and indicator reagent employed to determine the presence of a target analyte in a test sample, as well as the nature of the analyte itself.
[00135] Alternatively, steps of a reaction using the devices disclosed herein may be washed as follows. In certain embodiments, defined hydrophilic regions do not contain a reagent In such case, water or buffer is then added to the hydrophilic regions of the device and the fluid passes through the device along the sample flow path to provide a washing step for the analytes in the fluid sample. Such washing steps
can be used to remove unbound analyte or other components added for the detection of the presence of an analyte.
[00136] The hydrophilic regions can include one or more test areas that can be used to perform one or more assays for the detection of multiple analytes in the sample fluid. One or more of the hydrophilic regions can be treated with reagents that respond to the presence of analytes in a sample fluid and provide an indicator of the presence of an analyte in the sample fluid. In some embodiments, the detection of an analyte in the sample fluid is visible to the naked eye and can provide a color indicator of the presence of the analyte. In various embodiments, indicators may include molecules that become colored in the presence of the analyte, change color in the presence of the analyte, or emit fluorescence, phosphorescence, or luminescence in the presence of the analyte. In other embodiments, radiological, magnetic, optical, and/or electrical measurements can be used to determine the presence of proteins, antibodies, or other analytes in the sample flow path.
Methods of Making Encapsulated Paper-based Diagnostic Devices
[00137] In further exemplary embodiments, the present disclosure describes methods of making diagnostic devices, the methods including:
[00138] applying a hydrophobic hardenable (co)polymeric ink composition to an elongate web of a fibrous material, wherein the hydrophobic hardenable (co)polymeric ink composition is applied in a plurality of adjacent web regions extending from a first edge of the web to a second edge of the web, wherein each web region is separated from adjacent web regions by a border region; each and wherein each web region includes a hydrophobic area including the hydrophobic (co)polymeric ink composition, a hydrophilic area substantially free of the hydrophobic (co)polymeric ink composition;
[00139] positioning a second metallic or (co)polymeric substrate opposite the (co)polymeric film such that the folded web of fibrous material is positioned between the first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate; and
[00140] forming a plurality of edge seals around at least a perimeter of the folded web of fibrous material.
[00141] In some exemplary optional embodiments, the method further includes providing an optional compressible layer preferably positioned between at least one of the first metallic or (co)polymeric substrate and the porous substrate and/or the second metallic or (co)polymeric substrate and the porous substrate.
[00142] In certain of the foregoing methods, forming the plurality of edge seals around at least a perimeter of the folded web of fibrous material comprises stitching, needle punching, stapling, adhesive bonding, heat-sealing, shrink-wrapping, ultrasonic bonding, or a combination thereof.
[00143] Suitable stitching apparatus and methods are described, for example, in U.S. Pat. No. 5,962,102, the entire disclosure of which is incorporated herein by reference in its entirety.
[00144] Suitable needle punching apparatus and methods are described, for example, in U.S. Pat. No. 9,765,458, the entire disclosure of which is incorporated herein by reference in its entirety.
[00145] Suitable stapling apparatus and methods are described, for example, in U.S. Pat. No. 8,640,704, the entire disclosure of which is incorporated herein by reference in its entirety.
[00146] Suitable adhesive bonding apparatus and methods are described, for example, in U.S. Pat. No. 10,957,878, the entire disclosure of which is incorporated herein by reference in its entirety.
[00147] Suitable heat-sealing apparatus and methods are described, for example, in U.S. Pat. No. 10,759,980, the entire disclosure of which is incorporated herein by reference in its entirety.
[00148] Suitable shrink-wrapping apparatus and methods are described, for example, in U.S. Pat. No. 7,661,247, the entire disclosure of which is incorporated herein by reference in its entirety.
[00149] Suitable ultrasonic bonding apparatus and methods are described, for example, in U.S. Pat. No. 7,297,238; 7,731,823; 7,744,729; 7.820,249; 7,828,192; 7.980,536; 8,640,704; and 10,308,669, the entire disclosures of which are incorporated herein by reference in their entireties.
[00150] In some such embodiments, the plurality of edge seals comprise at least one heat-sealable (co)polymeric film, optionally wherein the plurality of edge seals comprise a first heat-sealable (co)polymeric film and a second heat-sealable (co)polymeric film, wherein a portion of each heat- sealable (co)polymeric film overlays opposed major surfaces of the folded web of fibrous material, further wherein the first and second heat-sealable (co)polymeric films are bonded to each other at a plurality of each heat-sealable (co)polymeric film’s edges which do not overlap the folded web of fibrous material.
[00151] In certain such embodiments, the first and second (co)polymeric substrate heat-sealable (co)polymeric films are independently selected from the group consisting of polyethylene films, polypropylene films, polybutylene films, polycarbonate films and polyester films.
[00152] In some presently preferred embodiments, the methods further include creating at least one access port in the diagnostic device by removing a portion of at least one of the first metallic or (co)polymeric film or the second metallic or (co)polymeric film in a region which overlaps the first hydrophilic region of the porous substrate. In certain presently preferred embodiments, the elongate porous substrate is chosen from paper, nonwoven materials, (co)polymeric films, and combinations thereof.
[00153] In additional presently preferred embodiments, the ink composition is applied to the elongate web of porous substrate by at least one of printing, coating, physical vapor deposition, and combinations thereof. In other presently preferred embodiments, the method further includes disposing a reagent in at least one of the hydrophilic areas along the flow path, wherein the reagent is selected to provide an indication of at least one of a presence, an absence, and a concentration of an analyte in the sample. [00154] Preferably, a roll-to-roll process is used to produce the diagnostic devices. In a roll-to-roll process, printing on the porous substrate is performed on a web line where the hydrophobic ink composition is printed on the substrate and then transported over an array of web idlers surfaces until it
reaches a UV lamp, which quickly solidifies the ink with UV radiation. To create a barrier print in the paper, it is a requirement that the hydrophobic ink reach the opposing surface of the paper before it is solidified. Between the time when the liquid ink reaches the opposing surface and when it is solidified, there is opportunity for traces of the liquid hydrophobic ink to contact and transfer to web line idlers.
This residual un-solidified liquid ink can then transfer to unpattemed hydrophilic regions of the substrate that passes over the idler at a subsequent time, which can potentially damage later-manufactured devices. [00155] In addition, for UV-cured inks and thick substrates, in some cases the total volume of printed ink can be a challenge to cure completely. In this case, it may be necessary to run the porous substrate through multiple UV radiation stations, and it may be difficult to achieve sufficient or complete polymerization of the radiation curable ink. If some of the ink remains unsolidified, the unhardened or partially-solidified ink can contaminate the processing equipment and the hydrophilic regions of the paper - making the diagnostic device ineffective. In some cases, splitting the UV-curing between two- sides of each layer can more fully polymerize the hydrophobic ink composition.
[00156] In some embodiments, mechanical fasteners may be used to temporarily maintain the alignment of one or more of the hydrophilic regions in overlying layers or panels of the diagnostic device, either alone or in combination with any of the adhesive layers described above. Suitable mechanical fasteners include, but are not limited to, plastic or metal clips, staples, elastic bands such as plastic or rubber bands, plastic zip ties and combinations thereof.
[00157] The mechanical fasteners may also be used to compress the stack of porous substrate layers and maintain intimate contact between layers, which in some examples can reduce wicking times between the layers. The hydrophilic regions in the layers should be in intimate contact with each other so that a liquid flows inside paper pores and not in gaps between the layers of the stack. In some examples, intimate contact between the layers of the stack can be enhanced by placing the arms of a clamping mechanical fastener along the edges or folds of the porous substrate.
[00158] Compression can be applied across the whole device or at the folded edges. Compressing the device can provide intimate contact between the layers of the diagnostic device, which can improve the flow of fluid through the layers by avoiding air gaps. In an embodiment, it may be advantageous to only compress the device at the edges. It was found that over-compression of the device decreases the porosity of the hydrophilic regions and inhibits the flow of fluid through the layers.
[00159] Compression of the device can be achieved when the edges of the device are dry or wet. Dry compression can be advantageous when wetting the device is undesirable. Wet compression can be advantageous by decreasing the resistance to bending the fibers at the edge of the device. Wetting of the device can be accomplished by applying a small amount of water along the edges of the device. Compression decreases the spring-like restoring forces of the folded device by bending or breaking the fibers at the edge of the device through high pressure. Additional methods of compressing the device include an arbor press, nipped-roller, other methods known in the art.
Methods of Using Encapsulated Paper-based Diagnostic Devices
[00160] In one embodiment, which is not intended to be limiting and is provided as an example, a sample solution (not shown in FIGS. 2A-4B) including a sample fluid, solvents, reagents, and the like, is placed on the sample port. A wash solution is then applied to the sample port, and the sample solution moves downward via capillary action through the hydrophilic regions of the respective panels of the sensor stack.
[00161] In certain embodiments, analytes may be detected by direct or indirect detection methods that apply the principles of immunoassays (e.g., a sandwich or competitive immunoassay or ELISA).
[00162] In some embodiments, to detect a specific protein, one or more areas of the hydrophilic regions can be derivatized with reagents, such as antibodies, ligands, receptors, or small molecules that selectively bind to or interact with a protein in the sample fluid. For example, to detect a specific antigen in a sample, a test area of the hydrophilic regions can be derivatized with reagents such as antibodies that selectively bind to or interact with that antigen. Alternatively, to detect the presence of a specific antibody in the sample fluid, a test area of the hydrophilic regions may be derivatized with antigens that bind or interact with that antibody.
[00163] For example, reagents such as small molecules and/or proteins can be covalently linked to the hydrophilic regions using similar chemistry to that used to immobilize molecules on beads or glass slides, or using chemistry used for linking molecules to carbohydrates. In alternative embodiments, the reagents may be applied and/or immobilized in the hydrophilic regions by applying a solution containing the reagent and allowing the solvent to evaporate (e.g., depositing reagent into the hydrophilic region). The reagents can be immobilized by physical absorption onto the porous substrate by other non-covalent interactions.
[00164] The interaction of certain analytes with some reagents may not result in a visible color change unless the analyte was previously labeled. The devices disclosed herein may be additionally treated to add a stain or a labeled protein, antibody, nucleic acid, or other reagent that binds to the target analyte after it binds to the reagent disposed in the sample flow path 32, which produces a visible color change. For example, the device may include a separate area that already contains the stain, or labeled reagent, and includes a mechanism by which the stain or labeled reagent can be easily introduced into the sample flow path to bond to the target analyte after it binds to the reagent.
[00165] Or, for example, the device can be provided with a separate channel that can be used to flow the stain or labeled reagent from a different area of the hydrophilic regions into test area along the sample flow path to the target analyte after it binds to the reagent in the sample flow path. In one embodiment, this flow is initiated with a drop of water, or some other fluid. In another embodiment, the reagent and labeled reagent are applied at the same location in the device, for example, in a test area of one of the hydrophilic regions along the sample flow path.
[00166] In one exemplary embodiment, ELISA may be used to detect and analyze a wide range of analytes and disease markers with the high specificity, and the result of ELISA can be quantified colorimetrically with the proper selection of enzyme and substrate.
[00167] Detection of an analyte in a sample fluid may include an additional step of creating digital data indicative of an image of a developed test area and the assay result, and transmitting the data remotely for further analysis to obtain diagnostic information, or to store assay results in an appropriate database. [00168] Some embodiments further include equipment that can be used to image the device after deposition of the liquid to obtain information about the quantity of analyte(s) based on the intensity of a colorimetric response of the device. In some embodiments, the equipment establishes a communication link with off-site personnel, e.g., via cellular phone communication channels, who perform the analysis based on images obtained by the equipment.
[00169] In some example embodiments, which are not intended to be limiting, the entire assay can be completed in less than 30 minutes, 20 minutes, 15 minutes, 10 minutes, or 5 minutes. In some example embodiments, the device can have a detection limit of about 500 pM, 250 pm, 100 pM, 1 pM, 500 fM, 250 fM, or 100 fM.
[00170] The diagnostic device of the present disclosure can be used for assaying small volumes of fluid samples. In various embodiments, the fluid samples that can be assayed include, but are not limited to, biological samples such as urine, whole blood, blood plasma, blood serum, sputum, cerebrospinal fluid, ascites, tears, sweat, saliva, excrement, gingival cervicular fluid, or tissue extract. In some embodiments, the volume of fluid sample to be assayed may be a drop of blood, e.g., from a finger prick, or a small sample of urine, e.g., from a newborn or a small animal. In some embodiments, the sample fluid is an environmental sample such as a water sample obtained from a river, lake, ocean or the like, or a sample of an industrial fluid. The device may also be adapted for assaying non-aqueous fluid samples for detecting environmental contamination.
[00171] In some embodiments, a single drop of liquid, e.g., a drop of blood from a pinpricked finger, is sufficient to perform assays providing a simple yes/no answer to determine the presence of an analyte in a sample fluid, or a semi-quantitative measurement of the amount of analyte that is present in the sample, e.g., by performing a visual or digital comparison of the intensity of the assay to a calibrated color chart. However, to obtain a quantitative measurement of an analyte in the liquid, a defined volume of fluid is typically deposited in the device.
[00172] Thus, in some embodiments, a defined volume of fluid (or a volume that is sufficiently close to the defined volume to provide a reasonably accurate readout) can be obtained by patterning the hydrophilic substrate to include a sample well that accepts a defined volume of fluid. For example, in the case of a whole blood sample, the subject's finger could be pinpricked, and then pressed against the sample well until the well was full, thus providing a satisfactory approximation of the defined volume. [00173] The assay reagents included in the device are selected to provide a visible indication of the presence of one or more analytes in the sample fluid. The source or nature of the analytes that may be
detected using the disclosed devices are not intended to be limiting. Exemplary analytes include, but are not limited to, toxins, organic compounds, proteins, peptides, microorganisms, bacteria, viruses, amino acids, nucleic acids, carbohydrates, hormones, steroids, vitamins, drugs, pollutants, pesticides, and metabolites of or, antibodies to, any of the above substances. Analytes may also include any antigenic substances, haptens, antibodies, macromolecules, and combinations thereof. For example, immunoassays using the disclosed devices could be adopted for antigens having known antibodies that specifically bind the antigen.
[00174] In exemplary embodiments, the disclosed devices may be used to detect the presence or absence of one or more viral antigens, bacterial antigens, fungal antigens, or parasite antigens, cancer antigens.
[00175] Exemplary viral antigens may include those derived from, for example, the hepatitis A, B, C, or E virus, human immunodeficiency virus (HIV), herpes simplex virus, Ebola virus, varicella zoster virus (virus leading to chicken pox and shingles), avian influenza virus, SARS virus, MERS virus, Epstein Barr virus, rhinoviruses, coronaviruses (such as, for example, the COVID19 coronavirus), and coxsackieviruses.
[00176] Exemplary bacterial antigens may include those derived from, for example, Staphylococcus aureus, Staphylococcus epidermis, Helicobacter pylori, Streptococcus bovis, Streptococcus pyogenes, Streptococcus pneumoniae, Listeria monocytogenes, Mycobacterium tuberculosis, Mycobacterium leprae, Corynebacterium diphtheriae, Borrelia burgdorferi, Bacillus anthracis, Bacillus cereus, Clostridium botulinum, Clostridium difficile, Salmonella typhi, Vibrio chloerae, Haemophilus influenzae, Bordetella pertussis, Yersinia pestis, Neisseria gonorrhoeae, Treponema pallidum, Mycoplasm sp., Legionella pneumophila, Rickettsia typhi, Chlamydia trachomatis, Shigella dysenteriae, and Vibrio cholera.
[00177] Exemplary fungal antigens may include those derived from, for example, Tinea pedis, Tinea corporus, Tinea cruris, Tinea unguium, Cladosporium carionii, Coccidioides immitis, Candida sp., Aspergillus fumigatus, and Pneumocystis carinii.
[00178] Exemplary parasite antigens include those derived from, for example, Giardia lamblia, Leishmania sp., Trypanosoma sp., Trichomonas sp., and Plasmodium sp.
[00179] Exemplary cancer antigens may include, for example, antigens expressed, for example, in colon cancer, stomach cancer, pancreatic cancer, lung cancer, ovarian cancer, prostate cancer, breast cancer, liver cancer, brain cancer, skin cancer (e.g., melanoma), leukemia, lymphoma, or myeloma. [00180] In other embodiments, the assay reagents may react with one or more metabolic compounds. Exemplary metabolic compounds include, for example, proteins, nucleic acids, polysaccharides, lipids, fatty acids, amino acids, nucleotides, nucleosides, monosaccharides and disaccharides. For example, the assay reagent is selected to react to the presence of at least one of glucose, protein, fat, vascular endothelial growth factor, insulin-like growth factor 1, antibodies, and cytokines.
[00181] As noted above, one or more reagents (not shown in FIGs. 2A-4B) may be included in any or all of the hydrophilic regions, and one or more of the panels may include a test area to indicate at least one of the presence, the absence, or the concentration of an analyte in a sample fluid.
[00182] In some embodiments (not shown in FIGS. 2A-4B), each web region may be printed on a separate web or area of a web. After the web is further processed, the individual web regions may then be aligned, placed over each other in a desired order, and stacked to form a suitable diagnostic device. However, in some cases the alignment and stacking steps in such a process may increase the overall manufacturing cost of the diagnostic device compared to the folding process described above.
[00183] In yet another aspect, the present disclosure is directed to assay methods including any of the embodiments of the diagnostic devices shown above. With reference to the diagnostic device 10 shown in FIGS. 2A-4B, example assay methods include adding a fluid sample including an analyte to the hydrophilic regions such that the sample fluid enters and wicks along the sample flow path by capillary action. In some embodiments, water or a buffer may also be added to the hydrophilic regions to assist in the movement of the sample fluid along the sample flow path.
[00184] Visual or machine examination of the test area within the hydrophilic regions, or over the entire hydrophilic regions, permits determination of at least one of a presence, absence, or concentration of the analyte in the fluid sample. For example, in some embodiments, the assay protocol produces a color reaction, which includes the development of a grey scale from black to white, and the examination of the development of or, intensity of, the color in the test area within the hydrophilic regions, or within the entire hydrophilic regions, to determine the presence, absence, or concentration of the analyte.
[00185] In one embodiment, an ELISA test may be conducted using the disclosed device. The method may include the steps of: (1) addition of a sample to the device, wherein the sample is wicked directly through the hydrophilic regions along the sample flow path (2) binding an analyte with a labeled antibody along the flow path and into the test area; and binding the analyte binds to an antigen in the test area; and optionally washing the hydrophilic regions with a buffer such as, for example, PBS, to observe the results in the test area.
[00186] In one embodiment, which is not intended to be limiting and provided as an example, a sample solution (not shown in FIGS. 2A-4B) including a sample fluid, solvents, reagents, and the like, is placed on the sample port. The sample solution and fluids may optionally be inserted through the access port in the packaging layer. A wash solution is then applied to the sample port, and the sample solution moves downward via capillary action through the hydrophilic regions of the respective panels of the sensor stack.
[00187] The operation of the present disclosure will be further described with regard to the following detailed examples. These examples are offered to further illustrate the various specific and preferred embodiments and techniques. It should be understood, however, that many variations and modifications may be made while remaining within the scope of the present disclosure.
EXAMPLES
[00188] These Examples are merely for illustrative purposes and are not meant to be overly limiting on the scope of the appended claims. Notwithstanding that the numerical ranges and parameters setting forth the broad scope of the present disclosure are approximations, the numerical values set forth in the specific examples are reported as precisely as possible. Any numerical value, however, inherently contains certain errors necessarily resulting from the standard deviation found in their respective testing measurements. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the claims, each numerical parameter should at least be construed in light of the number of reported significant digits and by applying ordinary rounding techniques.
Summary of Materials
[00189] Unless otherwise noted, all parts, percentages, ratios, etc. in the Examples and the rest of the specification are by weight. Solvents and other reagents used may generally be obtained from Sigma- Aldrich Chemical Company (Milwaukee, WI) unless otherwise noted.
[00190] The first and second (co)polymeric substrates used to encapsulate the porous substrates (e.g., paper) was a 5 mil thick PET film manufactured by 3M Company (Greenville, NC). Other materials are described in co-pending U.S. Prov. Patent Application 63/003,169, filed March 31, 2020 and titled “DIAGNOSTIC DEVICE” and co-pending U.S. Prov. Patent Applications 63/164,144, filed March 22, 2021 and titled “DIAGNOSTIC DEVICE.”
Test Methods
[00191] The importance of a predictable flow rate (equated to the time to flow through a diagnostic device to achieve a diagnostic result) was recognized as a key parameter for success of the final device. [00192] Lateral Wicking Rate was determined for lateral flow diagnostic devices by visual inspection of wicking of a test solution across a pre-determined measured lateral distance of the porous substrate. A stop-watch with 0.1 second resolution was used to measure the time required for the test solution to traverse the pre-determined measured lateral distance.
[00193] Vertical Wicking Rate was determined for vertical flow diagnostic devices using an electronic timing device that measured the time required for wicking of a test solution across a pre-determined measured vertical distance of the porous substrate.
[00194] Permeability through a porous substrate was measured to show that hydrophobic areas of selected porous substrates retained sufficient fluid permeability to be useful in a diagnostic device according to the present disclosure. A 5.08 cm (2 inch) diameter round disc was cut out of the porous substrate. The porous substrate samples were then inserted into a standard filter housing. A water line with one meter of static head pressure was then connected to the filter housing, and the outflow flow rate was measured.
Lateral Flow Device Examples
[00195] Lateral flow devices with a H/H (hydrophobic/hydrophilic) pattern with at least one “oval” (as opposed to an H/H pattern that contained only circles) were tested. The lateral flow devices were wetted
at an inlet port on the front face of the device and observed for wetting at the first circle and the end of
channel on the back (viewing) side of the device. Binder clipped (CE-1), plastic clipped (CE-2), and a device ultrasonically-bonded according to the present disclosure as shown in Fig. 2A (EX-1) were tested, the results of which are shown in Table 1.
Vertical Flow Devices Examples
[00196] The vertical flow devices were wetted at an inlet port on the front face of the device and observed for wetting on the back (viewing) side of the device. Observation was difficult by visual inspection, therefore an electronic measurement device described in the test methods was used to determine the time for flow through the device. A binder clipped (CE-3) device similar to Fig. 1 without ultrasonic welding and a device according to the present disclosure in Fig. 4 (EX-2) were tested, the results of which are shown in Table 2.
Table 2: Results for Vertical Flow Devices
Example 3:
[00197] A diagnostic device or assay device substantially similar to that described schematically in FIG. 4B was prepared that included a thick (about 60 mils or 1.5 mm) cardboard backer card and a clear pressure sensitive adhesive (PSA) tape outer packaging layer fixing the sensor stack to the baker card. The outer packaging layer included 2 apertures to provide access to the sensor stack, as well as a pull tab configured to strip away a predetermined portion of the outer packaging layer.
[00198] A compression layer of 90 mil (2.3 mm) closed cell polyethylene (PE) foam was attached to the backer card with an adhesive transfer tape. Above the foam layer was a wicking element including 2 sublayers of 0.9 mm wicking pads. The bottom sublayer of the wicking layer was attached to the top of
the foam layer with an adhesive transfer tape. The top sublayer wicking pad has laser-cut lateral flow control features such as shown in FIG. 10A.
[00199] The wicking pads were attached to each other with disks of an adhesive transfer tape which also blocked the wicking flow and facilitated the lateral flow control features. Above the top wicking pad the sensor stack was attached to the cover PSA tape with adhesive tape tabs.
[00200] A cover layer above the sensor stack was a 14 mil (0.36 mm) polyethylene terephthalate (PET) sheet. The cover layer included 2 apertures underlying the apertures in the outer packaging layer, which provided access to the sensor stack from above.
[00201] In another embodiment, the backing layer was a PET film that was ultrasonically welded about the periphery of the wicking layer. Preferably, the multilayer sensor stack and the optional compression layer, if present, are compressed before ultrasonically welding or otherwise bonding the backing layer about the periphery of the wicking layer. Preferably the ultrasonically welding or bonding of the backing layer about the periphery of the wicking layer acts to maintain the multilayer sensor stack in compression even after completion of the ultrasonic welding or bonding of the backing layer about the periphery of the wicking layer.
[00202] In another embodiment, the backing layer was 14 mil (0.36 mm) PET, and the outer packaging layer was an injection molded plastic shell. The plastic shell included apertures on an upper surface to provide access to the sensor stack.
[00203] The follow Preparative Examples illustrate methods of making various porous substrates suitable for preparation of edge-sealed diagnostic devices according to embodiments of the present disclosure.
Preparative Example 1 :
[00204] Flexographic ink (9418 obtained from NAZDAR Ink Technologies of Shawnee, KANS) was printed on a WHATMAN Grade 1 filter (obtained from GE Healthcare Life Sciences of Piscataway, NJ) paper substrate busing a FLEXIPROOF 100 printing system (obtained from RK Industries, Herts, United Kingdom). Printing was accomplished by using a 38.75 micrometer (25 billions of cubic microns (BCM)), 35.4 lines per centimeter (90 lines per inch) anilox roll to form a 5.08 cm (2 inch) diameter circle. After printing, the printed paper sample was heated for eight minutes at 177°C (350°F) and the ink was cured by exposure to UV radiation by a FUSION High Intensity UV curing system (obtained from FUSION UV Systems Inc of Hampshire, United Kingdom) outfitted with an H-bulb and conveyed at 1.5 meters (5 feet) per minute to form a hydrophobic region on the paper sample. After curing, the printed paper sample was tested for performance by depositing dyed deionized water into non-printed areas and visually inspecting the spread of the dyed water. The dye was added to water to help with observations. [00205] A test was performed to show that volumetrically hydrophobic areas of the paper retained sufficient fluid permeability. A 5.08 cm (2 inch) diameter round disk was cut out of the printed paper. The paper samples were inserted into a standard filter housing and a water line with one meter of head
pressure was connected to the filter housing and outflow was measured. Table 3 summarizes these test results.
Preparative Example 2:
[00206] A sample was created as described in Preparative Example 1 using NAZDAR OP 1028 ink (obtained from NAZDAR Ink Technologies of Shawnee, KANS) instead of the 9418 ink. A test was performed to show that volumetrically hydrophobic areas of the printed paper retained sufficient fluid permeability. A 5.08 cm (2 inch) diameter round disk was cut out of the printed paper. The paper samples were inserted into a standard filter housing and a water line with one meter of head pressure was connected to the filter housing and outflow was measured. Refer to Table 3 for test results.
Preparative Examples 3 - 5:
[00207] Three samples were created as described in Preparative Example 1 using a release ink UVF03408 (UV Easy Release) (obtained from Flint Group, Rogers, MN) instead of the 9418 ink. The first sample was undiluted. Before applying the ink, the second sample diluted the release ink by adding 20 percent isopropyl alcohol (IP A) solvent Before applying the ink, the third sample diluted the release ink by adding 40 percent IPA solvent. Samples with the solvent-containing ink were dried at room temperature for 15 minutes. A test was performed to show that volumetrically hydrophobic areas of the printed paper retained sufficient fluid permeability. A 5.08 cm (2 inch) diameter round disk was cut out of the printed paper. The paper samples were inserted into a standard filter housing and a water line with one meter of head pressure was connected to the filter housing and outflow was measured. Refer to Table 3 for test results.
Comparative Example 4:
[00208] A wax-saturated paper was made by melting Batik Wax (available from Jacquard Products, Healdsburg, CA) at 65.6°C (150°F) and dripping it on WHATMAN Grade 1 paper pre-heated to the
same temperature until saturation of less than about 5 minutes. A test was performed to show that volumetrically hydrophobic areas of the printed paper retained sufficient fluid permeability. A 5.08 cm (2 inch) diameter round disk was cut out of the printed paper. The paper samples were inserted into a standard filter housing and a water line with one meter of head pressure was connected to the filter housing and outflow was measured. Refer to Table 3 for test results.
Preparative Example 6:
[00209] A CH 265 self-adhering adhesive (obtained from Valpac Industries, Federalsburg, MD) was manually applied by a cotton swab onto the printed regions on both sides of the sample created in Preparatory Example 1. After drying at room temperature for one hour, the sample was folded and lightly pressed together. Dyed water was placed on one side of the sample and wicking to the other side was observed after 25 seconds indicating that fluid transport across layers was successful.
Preparative Example 7:
[00210] An adhesive was printed in an open mesh pattern onto the hydrophobic printed regions of a specific region of the configuration as described in Preparative Example 1.
[00211] The measured flow was highest for unprinted paper, followed by the printed paper. This shows that while printed paper remained permeable to water, flow through the wax-saturated disk was very low, which likely was due to delamination of wax under one meter of water pressure.
Preparative Example 8:
[00212] Flint Group Easy Release Coating (available from Flint Group, Rogers, MN) was flexographically printed on a 12-wide roll of Great Lakes filter paper (equivalent to #1 Whatman, Grade 601, available from Great Lakes Filters, Bloomfield Hills, MI) on custom-made flexographic printing line using 24 bcm (billion cubic microns), 100 lines per inch (about 40 lines per cm) anilox roll at 10 feet per minute (fpm; 5 cm/sec) line speed in a pattern representing an array of 5 folds of bio-diagnostics devices.
[00213] The ink was in-line UV cured on both sides in two passes. Single 5-fold devices were cut out of the roll of paper and folded along unprinted spaces between the prints. 3M spray adhesive (3M Spray Adhesive Super 77®, available from 3M Company, St. Paul, MN) was lightly sprayed by hand on both side of the device over both hydrophobic and hydrophilic areas.
[00214] After drying for 2 minutes, device was folded. Dyed water was placed on the top hydrophilic circle (covered with sprayed adhesive) and left to wick. Wicking to the other side was observed in about 50 seconds indicating that fluid transport across layers was successful.
Preparative Example 9:
[00215] In this example, we demonstrated dual-side registered patterning of a hydrophobic ink via the following steps:
[00216] In step (1), a hydrophobic ink available from Flint Group under the trade designation Easy Release (UVF03408) UV curable ink was flexographically printed using a 12 BCM/in2 anilox roll and a patterned LUX ITP60 flexographic printing plate (MacDermid Graphics Solutions, Atlanta, GA) at 20
ft/min (10 cm/sec) onto filter paper onto Great Lakes Filter Paper (Grade: CP51232 - Grade 601) obtained from Ahlstrom-Munksjo Filtration LLC), and the ink was transported to the UV curing station and solidified. The time between printing and curing was such that when the paper was transported at 20 ft/min (10 cm/sec), it provided enough time for the ink to wick approximately half the thickness of the filter paper.
[00217] In step (2), the printed paper from step (1) was then re-inserted through the printing line at 20 ft/min (10 cm/sec), and a second matching reverse-image pattern of the Flint Group Easy Release ink was printed in registration to the backside (i.e., opposing paper surface to the first pass of printing) of the filter paper. The printing was performed with a 12 BCM/in2 anilox roll and patterned LUX ITP60 flexographic printing plate. The printed paper was transported to the UV curing station and solidified at 20 ft/min (10 cm/sec), which was sufficient time for the hydrophobic ink to penetrate the paper and reach the other half-printed hydrophobic barrier layer, completing a barrier layer for a diagnostic device. [00218] The sample from step (2) of this example was tested with red-dyed water to ensure a complete seal was created throughout the thickness of the paper. The red-dyed water was deposited into the channels formed by the hydrophobic barriers, dried, and then photo-graphed.
Prophetic Example A:
[00219] Any of the porous substrates of Preparatory Examples 1-9 may be incorporated into am edge- sealed diagnostic device according to the present disclosure. The porous substrate may be positioned between first and second metallic or (co)polymeric substrates (e.g., 5 mil thick PET film manufactured by 3M Company, Greenville, NC) and then a plurality of edge seals may be formed between the first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate.
[00220] The plurality of edge seals around at least a portion of the perimeter of the folded web of fibrous material comprise stitching, needle punching, stapling, adhesive bonding, heat-sealing, shrink- wrapping, ultrasonic bonding, or a combination thereof. In some embodiments, the plurality of edge seals comprise at least one heat-sealable (co)polymeric film, optionally wherein the plurality of edge seals comprise a first heat-sealable (co)polymeric film and a second heat-sealable (co)polymeric film, wherein a portion of each heat-sealable (co)polymeric film overlays opposed major surfaces of the folded web of fibrous material, further wherein the first and second heat-sealable (co)polymeric films are bonded to each other at a plurality of each heat-sealable (co)polymeric film’s edges which do not overlap the folded web of fibrous material.
[00221] In certain embodiments, the first and second (co)polymeric substrate heat-sealable (co)polymeric films may be independently selected from the group consisting of polyethylene films, polypropylene films, polybutylene films, polycarbonate films and polyester films.
[00222] Alternatively, an ultrasonic bonding device may be used to bond together the first and second (co)polymeric substrates, thereby fully encapsulating the porous substrate.
[00223] Reference throughout this specification to "one embodiment," "certain embodiments," "one or more embodiments" or "an embodiment," whether or not including the term "exemplary" preceding the term "embodiment," means that a particular feature, structure, material, or characteristic described in connection with the embodiment is included in at least one embodiment of the certain exemplary embodiments of the present disclosure. Thus, the appearances of the phrases such as "in one or more embodiments," "in certain embodiments," "in one embodiment" or "in an embodiment" in various places throughout this specification are not necessarily referring to the same embodiment of the certain exemplary embodiments of the present disclosure. Furthermore, the particular features, structures, materials, or characteristics may be combined in any suitable manner in one or more embodiments. [00224] While the specification has described in detail certain exemplary embodiments, it will be appreciated that those skilled in the art, upon attaining an understanding of the foregoing, may readily conceive of alterations to, variations of, and equivalents to these embodiments. Accordingly, it should be understood that this disclosure is not to be unduly limited to the illustrative embodiments set forth hereinabove. Furthermore, all publications and patents referenced herein are incorporated by reference in their entirety to the same extent as if each individual publication or patent was specifically and individually indicated to be incorporated by reference.
[00225] Various exemplary embodiments have been described. These and other embodiments are within the scope of the following claims.
Claims
1. A diagnostic device, comprising: an elongate substantially planar porous substrate with a first end and a second end positioned between a first metallic or (co)polymeric substrate and a second metallic or (co)polymeric substrate such that the first and the second metallic or (co)polymeric substrates substantially surround and encapsulate the porous substrate, wherein the porous substrate comprises at least one folded region between the first end and the second end; a plurality of edge seals formed between the first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate; and optionally a compressible layer positioned between the first metallic or (co)polymeric substrate and the porous substrate and/or a compressible layer positioned between the second metallic or (co)polymeric substrate and the porous substrate; the diagnostic device optionally further comprising: a first portion of the porous substrate that lies in a first plane with respect to the folded region, wherein the first portion of the porous substrate comprises a first hydrophobic region and a first hydrophilic region, wherein the first hydrophobic region comprises a first low surface energy (co)polymeric material extending from a first major surface of the first portion of the porous substrate to a second major surface of the first portion of the porous substrate, and wherein the first hydrophobic region comprises an arrangement of interconnected open pores providing at least one uninterrupted path extending from the first major surface of the first portion of the porous substrate to the second major surface of the first portion of the porous substrate; and a second portion of the porous substrate that lies in a second plane with respect to the folded region, wherein the second plane is substantially parallel to the first plane, the second portion of the porous substrate comprising a second hydrophilic region and a second hydrophobic region comprising a second low surface energy (co)polymeric material, which may be the same or different from the first low surface energy (co)polymeric material, extending from a first major surface of the second portion of the porous substrate to second major surface of the second portion of the porous substrate, and wherein the second hydrophobic region comprises an arrangement of interconnected open pores providing at least one uninterrupted path extending from the first major surface of the second portion of the porous substrate to the second major surface of the second portion of the porous substrate; at least one connective region between the first portion of the porous substrate and the second portion of the porous substrate, wherein the at least one connective region is configured to maintain alignment of the first hydrophilic region and the second hydrophilic region sufficient to provide a sample flow path between the first portion of the porous substrate and the second
portion of the porous substrate along a direction normal to the first plane and the second plane; and a reagent along the sample flow path, wherein the reagent is selected to detect at least one of a presence, an absence or a concentration of an analyte present in a sample applied to the diagnostic device.
2. A diagnostic device, comprising: an elongate substantially planar porous substrate comprising a plurality of fibers, wherein a first end and a second end of the porous substrate is positioned between a first metallic or (co)polymeric substrate and the second metallic or (co)polymeric substrate such that the first and the second (co)polymeric substrates substantially surround and encapsulate the porous substrate, wherein the porous substrate comprises; a plurality of folded regions between the first end and the second end, the plurality of folded regions dividing the planar porous fibrous substrate into a stack of overlying substantially planar panels, wherein each of the panels in the stack occupies a different substantially parallel plane; a plurality of edge seals formed between the first and second metallic or (co)polymeric substrates around at least a portion of the perimeter of the porous substrate; and optionally a compressible layer positioned between the first metallic or (co)polymeric substrate and the porous substrate and/or a compressible layer positioned between the second metallic or (co)polymeric substrate and the porous substrate, optionally further wherein each of the panels comprises: at least one hydrophobic region comprising the fibers coated with a hydrophobic low surface energy (co)polymeric ink such that open areas remain between the fibers, the open areas between the fibers providing at least one uninterrupted open path between a first major surface of the panel and a second major surface of the panel, and at least one hydrophilic region; and wherein at least some of the panels comprise: a reagent selected to detect an analyte present in a sample, and a connective region configured to attach adjacent panels to each other, wherein the hydrophobic regions and hydrophilic regions in adjacent panels of the stack are aligned with each other to provide a sample flow path between the hydrophilic regions thereof along a direction normal to the first plane and the second plane such that the sample contacts the reagent disposed in the flow path to provide an indication of at least one of the presence, absence or concentration of the analyte in the sample.
3. The diagnostic device of claim 1 or 2, wherein the plurality of edge seals comprises at least one cured monomer, oligomer, or (co)polymer, or a combination thereof.
4. The diagnostic device of claim 3, wherein the plurality of edge seals comprise a first heat- sealable (co)polymeric film and a second heat-sealable (co)polymeric film, wherein a portion of each heat-sealable (co)polymeric film overlays an opposing major surface of the porous substrate, further wherein the first and second heat-sealable (co)polymeric films are bonded to each other at a plurality of each heat-sealable (co)polymeric film’s edges which do not overlap the porous substrate.
5. The diagnostic device of claim 4, further comprising at least one access port created by removing a portion of the first metallic or (co)polymeric substrate and/or the second metallic or (co)polymeric substrate, optionally in a region which overlaps the first hydrophilic region of the porous substrate.
6. The diagnostic device of claim 1 or 2, wherein the elongate porous substrate is chosen from paper, nonwoven materials, (co)polymeric films, and combinations thereof.
7. The diagnostic device of claim 6, wherein the elongate porous substrate comprises paper.
8. The diagnostic device of claim 1 or 2, wherein the optional hydrophobic regions and the optional hydrophilic regions are present, further wherein the hydrophobic regions substantially surround the hydrophilic regions.
9. The diagnostic device of claim 8, wherein the first and the second low surface energy (co)polymeric materials each comprise a radiation curable (co)polymeric ink.
10. The diagnostic device of claim 8, wherein the first and the second low surface energy (co)polymeric materials are formed by curing monomers, oligomers, (co)polymers or a combination thereof, optionally wherein the monomers, oligomers, or (co)polymers are selected from fluorocarbons, silicones, or hydrocarbons.
11. The diagnostic device of claim 8, wherein the first and the second low surface energy (co)polymeric materials comprise a hydrophobic ink with a surface energy lower than 35 dynes/cm.
12. The diagnostic device of claim 8, wherein the at least one connective region occupies a periphery of the panels and substantially surrounds the hydrophobic regions.
13. A method of making a diagnostic device, the method comprising: applying a hydrophobic hardenable (co)polymeric ink composition to an elongate web of a fibrous material, wherein the hydrophobic hardenable (co)polymeric ink composition is applied in a plurality of adjacent web regions extending from a first edge of the web to a second edge of the web,
wherein each web region is separated from adjacent web regions by a border region; each and wherein each web region comprises: a hydrophobic area comprising the hydrophobic (co)polymeric ink composition, a hydrophilic area substantially free of the hydrophobic (co)polymeric ink composition, and at least partially hardening the hardenable (co)polymeric ink composition in the hydrophobic areas of each web region to provide a hydrophobic ink on fibers of the fibrous material and open areas between the fibers, the open areas between the fibers providing at least one uninterrupted open ink-free flow path between a first major surface of the web and a second major surface of the web; and folding the web of fibrous material along the border regions to form a stack of overlying substantially planar panels, wherein each of the overlying planar panels in the stack occupies a different substantially parallel plane, and wherein each of the overlying planar panels comprises registered hydrophilic areas forming a sample flow path therebetween; and forming a plurality of edge seals around at least a portion of the perimeter of the folded web of fibrous material.
14. The method of claim 13, wherein forming the plurality of edge seals around at least a portion of the perimeter of the folded web of fibrous material comprises stitching, needle punching, stapling, adhesive bonding, heat-sealing, shrink-wrapping, ultrasonic bonding, or a combination thereof.
15. The method of claim 13, wherein the plurality of edge seals comprise at least one heat-sealable (co)polymeric film, optionally wherein the plurality of edge seals comprise a first heat-sealable (co)polymeric film and a second heat-sealable (co)polymeric film, wherein a portion of each heat- sealable (co)polymeric film overlays opposed major surfaces of the folded web of fibrous material, further wherein the first and second heat-sealable (co)polymeric films are bonded to each other at a plurality of each heat-sealable (co)polymeric film’s edges which do not overlap the folded web of fibrous material.
16. The method of claim 15, wherein the first and second heat-sealable (co)polymeric films are independently selected from the group consisting of polyethylene films, polypropylene films, polybutylene films, polycarbonate films and polyester films.
17. The diagnostic device of claim 15, further comprising at least one access port created by removing a portion of at least one of the first heat-sealable (co)polymeric film or the second heat-sealable (co)polymeric film, optionally in a region which overlaps the first hydrophilic region of the folded web of fibrous material.
18. The method of claim 13, wherein the elongate porous substrate is chosen from paper, nonwoven materials, (co)polymeric films, and combinations thereof.
19. The method of claim 13, wherein the ink composition is applied to the elongate web of porous substrate by at least one of printing, coating, physical vapor deposition, and combinations thereof.
20. The method of claim 13, further comprising disposing a reagent in at least one of the hydrophilic areas along the flow path, wherein the reagent is selected to provide an indication of at least one of a presence, an absence, and a concentration of an analyte in the sample.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163164144P | 2021-03-22 | 2021-03-22 | |
US63/164,144 | 2021-03-22 | ||
US202163200849P | 2021-03-31 | 2021-03-31 | |
US63/200,849 | 2021-03-31 | ||
US202163266054P | 2021-12-28 | 2021-12-28 | |
US63/266,054 | 2021-12-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022200867A1 true WO2022200867A1 (en) | 2022-09-29 |
Family
ID=80168085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2022/050692 WO2022200867A1 (en) | 2021-03-22 | 2022-01-26 | Edge-sealed porous substrate diagnostic devices and methods of making same |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2022200867A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230120911A1 (en) | 2020-03-31 | 2023-04-20 | 3M Innovative Properties Company | Diagnostic Device |
US12097498B2 (en) | 2020-12-31 | 2024-09-24 | 3M Innovative Properties Company | Nanopatterned films with patterned surface chemistry |
Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5962102A (en) | 1995-11-17 | 1999-10-05 | 3M Innovative Properties Company | Loop material for engagement with hooking stems |
US20040238052A1 (en) * | 2001-06-07 | 2004-12-02 | Nanostream, Inc. | Microfluidic devices for methods development |
US7297238B2 (en) | 2003-03-31 | 2007-11-20 | 3M Innovative Properties Company | Ultrasonic energy system and method including a ceramic horn |
US7661247B2 (en) | 2005-06-30 | 2010-02-16 | 3M Innovative Properties Company | Abrasive article packaging and method of making same |
US7828192B2 (en) | 2005-01-03 | 2010-11-09 | 3M Innovative Properties Company | Amplitude adjustment of an ultrasonic horn |
US7980536B2 (en) | 2002-02-15 | 2011-07-19 | 3M Innovative Properties Company | Mount for vibratory elements |
WO2011094342A1 (en) | 2010-01-26 | 2011-08-04 | 3M Innovative Properties Company | Low ghosting dry erase article and use thereof |
US8640704B2 (en) | 2009-09-18 | 2014-02-04 | 3M Innovative Properties Company | Flat-fold filtering face-piece respirator having structural weld pattern |
CN104624259A (en) * | 2015-01-25 | 2015-05-20 | 济南大学 | Preparation and application of simple high-throughput microfluidic chemiluminescence paper chip |
WO2015164112A1 (en) * | 2014-04-25 | 2015-10-29 | Siemens Healthcare Diagnostics Inc. | Microfluidic device |
US20150355132A1 (en) * | 2012-04-18 | 2015-12-10 | Richard M. Crooks | Method for the detection and quantification of analytes using three-dimensional paper-based devices |
EP2960055A2 (en) * | 2014-06-23 | 2015-12-30 | Xerox Corporation | System and method for forming bonded substrates |
US9597684B2 (en) | 2015-01-16 | 2017-03-21 | Xerox Corporation | Method for making hydrophobic barriers in paper |
US9669638B2 (en) | 2015-04-17 | 2017-06-06 | Xerox Corporation | System and method for forming hydrophobic structures in a hydrophilic print medium |
US9765458B2 (en) | 2005-12-14 | 2017-09-19 | 3M Innovative Properties Company | Mounting mat for a pollution control device |
US10308669B2 (en) | 2013-12-19 | 2019-06-04 | 3M Innovative Properties Company | Laminated articles for microbial removal and low pressure drop filtration, methods of making, and methods of using same |
US10759980B1 (en) | 2015-12-22 | 2020-09-01 | 3M Innovative Properties Company | Packaged pre-adhesive composition including a polylactic acid-containing packaging material, adhesives, and articles |
US10957878B2 (en) | 2012-07-20 | 2021-03-23 | 3M Innovative Properties Company | Structured lamination transfer films and methods |
-
2022
- 2022-01-26 WO PCT/IB2022/050692 patent/WO2022200867A1/en active Application Filing
Patent Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5962102A (en) | 1995-11-17 | 1999-10-05 | 3M Innovative Properties Company | Loop material for engagement with hooking stems |
US20040238052A1 (en) * | 2001-06-07 | 2004-12-02 | Nanostream, Inc. | Microfluidic devices for methods development |
US7980536B2 (en) | 2002-02-15 | 2011-07-19 | 3M Innovative Properties Company | Mount for vibratory elements |
US7297238B2 (en) | 2003-03-31 | 2007-11-20 | 3M Innovative Properties Company | Ultrasonic energy system and method including a ceramic horn |
US7731823B2 (en) | 2003-03-31 | 2010-06-08 | 3M Innovative Properties Company | Ultrasonic energy system and method including a ceramic horn |
US7744729B2 (en) | 2003-03-31 | 2010-06-29 | 3M Innovative Properties Company | Ultrasonic energy system and method including a ceramic horn |
US7820249B2 (en) | 2003-03-31 | 2010-10-26 | 3M Innovative Properties Company | Ultrasonic energy system and method including a ceramic horn |
US7828192B2 (en) | 2005-01-03 | 2010-11-09 | 3M Innovative Properties Company | Amplitude adjustment of an ultrasonic horn |
US7661247B2 (en) | 2005-06-30 | 2010-02-16 | 3M Innovative Properties Company | Abrasive article packaging and method of making same |
US9765458B2 (en) | 2005-12-14 | 2017-09-19 | 3M Innovative Properties Company | Mounting mat for a pollution control device |
US8640704B2 (en) | 2009-09-18 | 2014-02-04 | 3M Innovative Properties Company | Flat-fold filtering face-piece respirator having structural weld pattern |
WO2011094342A1 (en) | 2010-01-26 | 2011-08-04 | 3M Innovative Properties Company | Low ghosting dry erase article and use thereof |
US20150355132A1 (en) * | 2012-04-18 | 2015-12-10 | Richard M. Crooks | Method for the detection and quantification of analytes using three-dimensional paper-based devices |
US10957878B2 (en) | 2012-07-20 | 2021-03-23 | 3M Innovative Properties Company | Structured lamination transfer films and methods |
US10308669B2 (en) | 2013-12-19 | 2019-06-04 | 3M Innovative Properties Company | Laminated articles for microbial removal and low pressure drop filtration, methods of making, and methods of using same |
WO2015164112A1 (en) * | 2014-04-25 | 2015-10-29 | Siemens Healthcare Diagnostics Inc. | Microfluidic device |
EP2960055A2 (en) * | 2014-06-23 | 2015-12-30 | Xerox Corporation | System and method for forming bonded substrates |
US9597684B2 (en) | 2015-01-16 | 2017-03-21 | Xerox Corporation | Method for making hydrophobic barriers in paper |
CN104624259A (en) * | 2015-01-25 | 2015-05-20 | 济南大学 | Preparation and application of simple high-throughput microfluidic chemiluminescence paper chip |
US9669638B2 (en) | 2015-04-17 | 2017-06-06 | Xerox Corporation | System and method for forming hydrophobic structures in a hydrophilic print medium |
US10759980B1 (en) | 2015-12-22 | 2020-09-01 | 3M Innovative Properties Company | Packaged pre-adhesive composition including a polylactic acid-containing packaging material, adhesives, and articles |
Non-Patent Citations (3)
Title |
---|
"WETTABILITY (SURFACTANT SCIENCE", 20 April 1993, CRC PRESS |
A. W. MARTINEZ ET AL: "From the Cover: Three-dimensional microfluidic devices fabricated in layered paper and tape", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 105, no. 50, 16 December 2008 (2008-12-16), pages 19606 - 19611, XP055042226, ISSN: 0027-8424, DOI: 10.1073/pnas.0810903105 * |
FRANCOISE BROCHARD-WYARTDAVID QUERE, HARDCOVER: "CAPILLARITY AND WETTING PHENOMENA DROPS, BUBBLES, PEARLS, WAVES", 12 September 2003, SPRINGER |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230120911A1 (en) | 2020-03-31 | 2023-04-20 | 3M Innovative Properties Company | Diagnostic Device |
US11744915B2 (en) | 2020-03-31 | 2023-09-05 | 3M Innovative Properties Company | Diagnostic device |
US12097498B2 (en) | 2020-12-31 | 2024-09-24 | 3M Innovative Properties Company | Nanopatterned films with patterned surface chemistry |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2022200867A1 (en) | Edge-sealed porous substrate diagnostic devices and methods of making same | |
WO2022200868A1 (en) | Encapsulated porous substrate diagnostic devices and methods of making same | |
US20130084630A1 (en) | Quantitative microfluidic devices | |
US20110124130A1 (en) | Device and method for analysis of samples with depletion of analyte content | |
EP1915604A2 (en) | Microfluidic devices and methods of preparing and using the same | |
WO2011097412A1 (en) | Devices and methods for multiplexed assays | |
EP2426498A1 (en) | Simple membrane assay device | |
JPH07503536A (en) | Simultaneous drug testing and fingerprinting assay | |
WO2014053237A1 (en) | Multilayer microfluidic device and assay method | |
JP2006201091A (en) | Micro particle for capture beads, capture beads using same, and biochip | |
WO2023026820A1 (en) | Solution supply device, detection set, and detection method | |
CA2289713C (en) | Immunoassay apparatus | |
WO2022200866A1 (en) | Ultrasonically-bonded porous substrate diagnostic devices and methods of making same | |
EP1879028B1 (en) | Use of albumin, bovine, p-aminophenyl n-acetyl ß-d glucosaminide as a positive control line in an immunoassay device | |
WO2022208321A1 (en) | Curved diagnostic device | |
US6224831B1 (en) | Microassay device and methods | |
KR20090101823A (en) | Immunochromatographic kit for use in immunoassay and manufacturing method of the same | |
US20230138304A1 (en) | Diagnostic Device | |
Benhabib et al. | Low-cost assays in paper-based microfluidic biomedical devices | |
WO2023224993A1 (en) | Rapid detection tests and methods of forming the same | |
WO2022203025A1 (en) | Inspection device and inspection method | |
JP6642874B2 (en) | Lateral flow testing and related improvements | |
US11744915B2 (en) | Diagnostic device | |
JP6357616B2 (en) | Sheet immunoassay | |
TWI258586B (en) | Immunochemical detection device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22702317 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 22702317 Country of ref document: EP Kind code of ref document: A1 |